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1 Abstract  
Cell cycle checkpoints are critical regulatory processes ensuring the proper traversal 
of a cell through the cell cycle. Activation of checkpoints in response to different 
types of DNA damage arrests the normal cell cycle progression at different stages, 
presumably to allow time for repair. ATM (Ataxia-telangiectasia mutated) and ATR 
(ATM and Rad3-related) are critical players in G2 checkpoint response. It is still 
unknown whether the contribution of ATM and ATR to checkpoint activation is 
through independent inputs from parallel signaling cascades, or whether the two 
kinases contribute in a sequential manner, in the sense that the activation of one is 
enhanced by the activation of the other. 
 
Here, we use flow cytometry-based measurement of DNA-content and mitotic index 
variations to detect G2 checkpoint activation and maintenance after exposure of cells 
with different genetic background to ionizing radiation (IR). Extensive experiments 
using different cell lines and an array of inhibitors confirm that ATR signaling plays a 
dominant role in the development of a full scale G2 arrest, while ATM signaling 
ensures the maintenance of a full scale G2 arrest.  
 
In response to IR, ATRIP (ATR interacting protein) and ATM phosphorylated at 
serine 1981 (ATM-pS1981) show local accumulation on chromatin that is detected in 
the form foci by immunofluorescence microscopy. Immunofluorescence detection of 
ATRIP and ATM-pS1981 foci reveals a linkage between foci formation and G2 
checkpoint activation. Although ATR plays a dominant role in G2 checkpoint 
signaling, its activation for G2 arrest may not coincide with foci formation since visible 
foci form relatively late (1 h after IR). The contribution of ATM to G2 arrest, as 
indicated by the formation of ATM-pS1981 foci, is strongly dependent on the cell 
cycle phase in which the cell is irradiated. To investigate this aspect in greater detail, 
we introduced multicolor staining protocols utilizing appropriate cell cycle makers that 
allow cell cycle stage characterization before and after irradiation. By combining 
ATM-pS1981 foci kinetics with cell cycle information, we observed an apparent 
requirement for about 20 foci for the maintenance of the G2 arrest for cells irradiated 
in the G2-phase. There is no apparent correlation between ATM-pS1981 foci and G2 
arrest for cells irradiated in the G1-phase, as in this case foci disappear relatively 
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quickly. Interestingly, cells irradiated throughout S-phase, show a response similar to 
that observed with G2 cells and not, as one would expect, a mixed response 
reflecting subpopulations responding like G1 and subpopulations responding like G2 
cells.  
 
Key words, ATM, Chk2, ATR, Chk1, phosphorylation, ATM foci, G2 checkpoint  
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2 Introduction 
2.1 Cell cycle progression and Checkpoint activation 
Cell cycle checkpoints are critical regulatory processes ensuring the proper traversal 
of a cell through the cell cycle. They include responses that enforce the right 
sequence in cell progression through the cell cycle, contribute to the repair of DNA 
damage, ensure the high fidelity of DNA replication, and assist in the proper 
chromosome segregation at mitosis (1,2). Checkpoints are highly conserved in all 
eukaryotes (3). Activation of checkpoints in response to different types of DNA 
damage arrests the normal cell cycle progression at different phases, presumably to 
allow time for repair. Checkpoint deficiency causes genomic instability and has been 
implicated in carcinogenesis (3). The cell cycle and checkpoints are illustrated in 
Figure 1.  
 
 
 
 
 
 
 
 
Figure 1. Cell cycle and checkpoint control. Four cell cycle stage and three checkpoints are 
depicted. Because the intra-S checkpoints are distributed throughout the S-phase, they do not show in 
the picture. 
2.1.1 The G1 checkpoint 
It is generally thought that the tumour suppressor p53 plays an essential role in 
controlling the G1/S checkpoint (4). After the occurrence of DNA damage, p53 
G1
M
S 
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G1 checkpoint
G2 checkpoint
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mediates transcriptional up-regulation of p21. p21 binds a series of Cdk-cyclin 
complexes, like for example cdk4-cyclin D, Cdk6-cyclin D, Cdk2-cyclin E, as well as 
Cdk2-cyclin A, and inhibits their activities. This inhibition transiently arrests cells in 
their transition from G1 into S (4-7).  
2.1.2 G2 checkpoint 
The activation of the G2 checkpoint delays mitotic entry in the presence of DNA 
damage. Because the spindle checkpoint at mitosis only responds to spindle 
damages or mis-attached chromosomes (8), the G2 checkpoint is the last chance for 
correcting genomic damage prior to cell division (9). This fact probably explains its 
importance in the overall checkpoint response. The proteins participating in the 
activation of the G2 checkpoint are highly conserved in eukaryotes (10). It is well 
documented that the ultimate target of the initiated G2 checkpoint signal transduction 
pathway is Cdc2 (Cdk1) (1,11-13). In G2, this cyclin dependent kinase (Cdk) is 
activated after binding to cyclin B1, by a phosphorylation at Threonine-161 and a 
dephosphorylation at Threonine-14/Tyrosine-15 (1). In this stage, Cdk1 is associated 
with cyclin B1 and forms the so called mitosis promotion factor (MPF). Checkpoint 
mediated delay in G2 can be enhanced by a delay in the removal of the inactivating 
phosphorylation in Thr-14/Tyr-15 (see above). Furthermore, several variations in the 
signal transduction cascade upstream of Cdk1 have been proposed, depending on 
the presence of p53 (14). p53 and p21 are believed to contribute to the G2 
checkpoint by up-regulating the 14-3-3 proteins. High levels of 14-3-3 inhibit MPF by 
inhibiting the activity of Cdc25C, which is responsible for the dephosphorylation of 
Cdk1 at Tyr-15 (15). Interaction of Cdc25C with 14-3-3 proteins is increased after 
phosphorylation of Cdc25C by Chk1 or Chk2 and leads to the translocation of 
Cdc25C to the cytoplasm and its subsequent degradation. Ataxia-telangiectasia 
mutated (ATM) and ATM and Rad3-related (ATR) are putative critical players in G2 
checkpoint activation independently of p53; ATR and ATM mediate the activation of 
Chk1 and Chk2, respectively (16-18).  
2.1.3 DSBs are very effective to activate checkpoints 
The DNA double-strand breaks (DSBs) are the principle cytotoxic lesions induced by 
ionizing radiation (IR). They are also induced as a consequence of chemical 
treatments (hydroxyurea, etoposide, bleomycin) (19,20), as well as of mechanical 
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stress (21). They can also be accidentally induced by abrogation of normal biological 
events, such as the collapse of a replication fork, and are produced in a programmed 
fashion during V(D)J and class switch recombination in developing lymphoid cells, as 
well during meiosis (22-24). DSBs must be properly handled. Unrepaired or 
misrepaired DSBs can lead to mutations or genomic instability (25). DSBs are very 
effective in triggering the activation of cell cycle checkpoints, presumably to provide 
time for repair (3,26,27). 
2.2 ATM-Chk2 and ATR-Chk1 signaling in G2 checkpoint 
 
ATM and ATR are key players in checkpoint response and their activations are 
essential for the maintenance of genomic integrity after DNA damage (10,28,29). 
ATM, ATR, as well as the DNA dependent protein kinase catalytic subunit (DNA-
PKcs) are large protein kinases with molecular weight of 370, 301 and 450 KD 
respectively. They share sequence homology with the phosphoinositide-3 lipid family 
of kinases (PI-3Ks) but work exclusively on proteins (30-32) by  phosphorylating 
serines and threonines at the consensus sites SQ/TQ. All three proteins contain 
themselves clusters of SQ/TQ motifs (33) allowing thus autophosphorylation, Figure 
2. As a result of the preference of these kinases for SQ/TQ motifs, they are 
considered structural hallmarks of DNA-damage-response proteins (34-36). Due to 
their high rank in the DSB induced signal transduction cascade, all PI-3Ks (ATM, 
ATR and DNA-PKcs) are considered sensors of cellular genotoxic stress (37).  
 
 
 
 
 
 
 
ATR 
2644aa1aa 
FATSQ/TQ PI-3K 
 
FATC 
DNA-PKcs 
4128aa1aa 
FATSQ/TQ PI-3K 
 
FATC 
ATM 
Leucine zipper
3056aa1aa 
Ser1981
NLS FATHEAT Repeat NLS SQ/TQ NLS
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Figure 2. The Structure of PI-3K like family members. Conserved domains of PI-3K like family 
members are depicted in different colours. In detail:  FAT (FRAP, ATM, TRRAP domain); FATC (FAT 
C-terminal domain); PI3-K (phosphatidylinositol 3-kinase domain); HEAT Repeat (Huntingin, 
elongation factor 3 (EF3), protein phosphotase 2A (PP2A), TOR1 domain); NLS: (Nuclear Localization 
Signal domain). SQ/TQ: SQ/TQ cluster. Ser1981 indicates Serine 1981, which is the major 
phosphorylation site of ATM, see below. 
2.2.1 The ATR-Chk1 signaling pathway 
Although ATR is activated in response to many different types of DNA damage, the 
ssDNA (single-stranded DNA) which is generated as a result of stalled DNA 
replication or during processing of chromosomal lesions appears to be central to the 
activation of ATR. Several alternative mechanisms are reported in the activation of 
ATR (38,39). But RPA (replication protein A)-coated ssDNA (single-stranded DNA) is 
crucial for the localization of ATR to sites of DNA damage, which is observed in both 
human and budding yeast systems (40,41). ATR is recruited to DNA lesions in part 
through its association with ATR-interacting protein (ATRIP) (41,42), which in turn 
interacts with RPA (40,43,44). Although RPA–ssDNA might be sufficient to localize 
the ATR–ATRIP complex, it is not sufficient for ATR activation (45,46). ATR signaling 
is dependent on the colocalization of the ATR–ATRIP complex with the 9-1-1 
complex (RAD9–RAD1–HUS1 complex), a heterotrimeric ring-shaped molecule that 
is related in structure and sequence to PCNA (proliferating cell nuclear antigen) (47-
50). Rfc2-Rfc5 (a component of the replication factor-C complex), as well as Rad17 
replacing Rfc1, are also reported involved in ATR activation (50,51).  
In S. cerevisiae, the 9‑1‑1 complex has been reported to directly activate ATR (52). 
But there is no evidence that this direct activation occurs in other organisms (18). 
The 9‑1‑1 complex brings TOPBP1 (topoisomerase-binding protein-1) to ATR (53,54). 
TOPBP1 is a breast cancer-1 (BRCA1) C-terminal (BRCT)-domain-containing protein 
that is necessary for ATR activation in vitro (55). The mechanism by which TOPBP1 
binding activates ATR remains to be elucidated. The primary binding site for the 
activation domain of TOPBP1 on the ATR complex is within ATRIP, and mutations in 
this region of ATRIP block the activation of ATR (56,57).  
Although the majority of RPA-coated ssDNA is generally present only during DNA 
replication, activation of ATR is not restricted to S-phase cells (45,58,59). In G1 and 
G2-phase, ATR activation might still require formation of RPA-coated ssDNA, 
through mechanisms, which might be different from those operating during S-phase 
(28). IR induced DSBs will be rapidly processed to ssDNA by various exonucleases, 
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including Mre11 (60). The recruitment of replication RPA to ssDNA facilitates the 
recruitment of several complexes of checkpoint proteins (40,61). In this context, ATR 
is activated and then phosphorylates Chk1, activating it in the process and allowing it 
to enforce a block in mitotic entry (28). Chk1, a serine/threonine protein kinase, is 
phosphorylated at serines 317 and 345 (SQ/TQ site) and thus activated by ATR 
(51,62,63). Several proteins are required for this process (10). Claspin is crucial for 
this activation, functioning to bring ATR and CHK1 together (48). 
As indicated above, activated Chk1 targets its major substrate Cdc25C to negatively 
regulate its activity by facilitating its degradation (64-66). Low level Cdc25C 
suppresses dephosphorylation of Tyr-15 on Cdk1, which keeps MPF inactive, thus 
blocking progression into M. This final event completes the signal transduction from 
the DNA damage to the ultimate cell cycle arrest (67,68). Chk1 is not only required 
for checkpoint initiation but it is also needed to maintain the G2 checkpoint (69). 
Inactivation of Chk1 during G2 leads to a premature termination of the checkpoint 
that frequently results in catastrophic mitotic events (70). 
2.2.2 The ATM-Chk2 signaling pathway 
Exposure of cells to IR triggers ATM kinase activity, and this function is required for 
the complete activation of checkpoints in G1, S and G2 phases of the cell cycle 
(71,72). The quick induction of ATM kinase activity following IR suggests that it might 
act at an early stage of signal transduction in mammalian cells (73). DNA DSBs lead 
to the accumulation of the MRN (Mre11, Rad50 and Nbs1) complex, which binds to 
DSBs as a heterotetramer (74). MRN complex accumulation at DSB end is MDC1 
(mediator of DNA-damage checkpoint protein-1) dependent (75). The retention of the 
MRN complex at the sites of DSBs increases its local concentration. ATM also 
arrives early at the DSB site (76). Interaction of MDC1 through its FHA domain with 
ATM regulates the accumulation of ATM at damage sites (77).  
The expression level of ATM remains stable throughout the cell cycle and is not 
changed in response to IR; and  the regulation of ATM mainly occurs through post 
translational modifications (78). ATM is held inactive in unirradiated cells as a dimer 
or a higher-order multimer in a form that masks the serine-1981 (an “SQ/TQ”) site 
(36). IR triggers the rapid autophosphorylation of serine-1981 (ATM-pS1981) that 
causes dimer dissociation and initiates monomer formation (78). Evidence suggest 
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that ATM kinase activity elevation is not regulated by this phosphorylation but rather 
by the disruption of the dimer, which allows access and phosphorylation of down 
stream ATM substrates (78). Although DSBs can elevate ATM kinase activity, it 
remains unclear precisely how ATM is activated by DSBs. Some evidence suggests 
that it is not activated by binding directly to DSBs, but by the alterations in higher-
order chromatin structure (78-80). Others suggest that direct binding ATM to DSB 
ends is a crucial step in its activation (81).  
Several substrates of the ATM kinase participate in checkpoints activated throughout 
the cell cycle. These include p53, Mdm2 and Chk2, Nbs1, Brca1, FancD2 and SMC1, 
hRad17, H2AX and others (29,73,78,82,83). The MRN complex 
(Mre11/Rad50/NBS1), is not only involved in the activation of ATM, but it is also a 
target for ATM kinase in downstream signaling to the DNA-repair machinery and the 
cell-cycle checkpoints (84). It is now well established that NBS1 is rapidly recruited to 
a DSB, where it remains stably bound (85). The stable binding of MRN to the break 
site and its co-localization with ATM makes it an ideal candidate to facilitate 
downstream substrate phosphorylation (75).  
With the involvement of MRN complex, ATM transduces a genotoxic stress signal by 
activating its downstream substrate Chk2 (86). Chk2, the mammalian homolog of the 
Saccharomyces cerevisiae Rad53 and Schizosaccharomyces pombe Cds1 protein 
kinases, is required for the overall DNA damage response and specifically for the 
activation of the DNA replication checkpoints (87). Such activation occurs by 
phosphorylation of Chk2 at Thr68, a SQ/TQ site by ATM (17,88). Chk2 transduces 
the signal by phosphorylating Cdc25C at serine-216, a site known to be involved in 
the negative regulation of Cdc25C (89-91). The same site is phosphorylated by Chk1, 
which suggests that, in response to DNA damage and DNA replication stress, the 
ATR-Chk1 and ATM-Chk2 pathways converge at phosphorylating Cdc25C to prevent 
entry into mitosis (90,92).  
2.2.3 The significance of two converging signaling pathways 
The deficiency of ATM and ATR are associated with distinct consequences at the cell 
level. ATR is essential for early embryonic development, with Atr−/− embryos dying at 
an early developmental stage. Art−/− blastocysts cycle into mitosis but soon thereafter 
fail to expand and die of caspase-dependent apoptosis (93). However, individuals 
Introduction 
 9
partially defective in ATR can survive but suffer from the Seckel syndrome, a 
microcephalic primordial dwarfism syndrome. Seckel cells show high radiosensitivity 
and an impaired G2 checkpoint (94). Unlike mammalian cells, ATR deficiency is not 
lethal in plant cells but elicits abnormal G2 arrest in response to IR (95). In yeast, 
however, the essential function of Mec1, the ATR homologue, has little to do with 
cell-cycle arrest or origin firing, but is related to the fork-stabilization activity of the 
protein (96). Chk1 deficiency is embryonic lethal in mice (62). And the conditional 
knockout of Chk1 in cells using the cre-loxP system shows a defective G2 arrest (62). 
Complete depletion of Chk1 leads to premature activation of MPF that is followed by 
mitotic catastrophe (97). Chk1-deficient DT40 cells are viable, but fail to arrest in G2 
in response to IR and are radiosensitive to killing (98). 
Unlike ATR, deficiency in ATM is not embryonic lethal. The ATM deficiency 
associates with the human disease ataxia–telangiectasia (AT), and abrogates 
responses to ionizing radiation in mammalian cells. Cells from AT patients typically 
lack detectable ATM protein, contain abnormalities in telomere morphology and have 
abnormal responses to IR, including increased cell death, increased chromosomal 
breakage and cell-cycle checkpoint defects (99). AT patients exhibit progressive 
cerebellar ataxia, immune deficiencies, gonadal atrophy, oculocutaneous 
telangiectasias, radiation sensitivity, premature ageing and increased risk of cancers 
(71,100). Chk2-deficient mice are also viable but exhibit radioresistance and are 
defective in p53-mediated transcription (101). Cells derived from Chk2-/- mice were 
found significantly impaired in the IR-induced G1 checkpoint and in apoptosis. On the 
other hand, the checkpoints in G2 or S-phase appear normal (101,102). Chk2 
cooperates with Brca1 in the induction of breast cancer (103). Chk2 mutations are  
also found in patients with Li-Fraumeni syndrome, a syndrome linked to mutations of 
the p53 tumor suppressor gene (104). 
The above outlined pathways are highly conserved in different organisms, such as 
Drosophila and mammals (2,105,106), which suggests that they play important but 
different and possibly complementing roles in the checkpoint response (107). 
However Tel1 and Mec1 (the yeast ATM and ATR homologues, respectively) have 
been found redundantly implicated in the DNA damage repair and telomere integrity 
of Saccharomyces cerevisiae (108,109).  
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2.2.4 Cross talk and mutual regulation between the ATM-Chk2 and ATR-Chk1 
signaling pathways 
The standard dogma in the field of DNA damage response is that the ATR-Chk1 
pathway is mainly activated by UV light-induced DNA damage and by stalled 
replication forks, while the ATM-Chk2 pathway is activated in response to IR-induced 
DSBs (110-113). However, evidence is emerging that ATR and ATM are not acting in 
an independent fashion in the checkpoint response but rather that they cooperate to 
induce and maintain the checkpoint response (114). A summary of the ATM-Chk2 
and ATR-Chk1 pathways co-operating to maintain the G2 checkpoint signaling 
cascade is shown in Figure 3. Mec1 and Tel1 in yeast are reported to function 
redundantly in the DNA DSB repair and telomere length regulation (109,115). The 
overlap in substrate specificity between ATM and ATR also suggests the possibility 
for a crosstalk between the two pathways; BRCA1 and p53 are phosphorylated by 
both kinases (116-118).  
The ATM and MRN complexes are required for the processing of DSBs and to 
generate RPA-coated ssDNA, which then mediates ATR/Chk1 activation (41,119). 
Efficient ATM-dependent ATR activation is restricted to the S and G2 phases of the 
cell cycle, and requires the CDK kinase activity (16,119). Some evidence suggests 
that ATM deficiency causes an elevation of ATR activity to sustain Chk2 
phosphorylation in response to IR (120). Hence ATM may be located upstream of 
ATR (121).  
The hallmark of ATM autophosphorylation at Ser1981 after IR is not observed after 
UV irradiation, or replication fork stalling. In this case, ATR alone, without ATM and 
the MRN complex, is required for checkpoint signaling (122). Furthermore, after 
depletion of endogenous ATM or ATR, a chimeric protein  by fusing ATM to the 
ATRIP binding domain of ATR can partly restore checkpoint function, although the 
full complementation is not achieved (123). Detailed genetic analysis of Chk1 and 
Chk2 homologues in different species also reveals a cross talk between the ATM-
Chk2 and ATR-Chk1 pathways in fungi, as well as in humans (124,125). 
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Figure 3. Putative G2 arrest signal transduction network (adapted from Cell Signaling 
Technology®). The G2 arrest signal transduction pathways in response to radiation (ionizing radiation 
and UV radiation). ATM and ATR play central roles in the G2 arrest pathway(s). 
Crosstalk occasionally observed at the level of Chk1 and Chk2 (such as ATM-
dependent Chk1 phosphorylation after exposure to IR (126)) probably result from 
interconversion of the DNA lesions. End resection converts DSBs into ssDNA 
structures that activate ATR, whereas nucleases can cleave ssDNA to yield DSBs 
that activate ATM (18). 
2.3 Foci formation 
In response to IR, many proteins involved in the response mounted by the cell show 
a local modification or accumulation, which can de detected under the microscope by 
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immunofluorescence staining as a “focus” forming in the nucleus. Proteins with such 
properties include H2AX-pS139 (γ-H2AX), ATF2-pS490/498, pSMC1-pS957，Chk2-
pT68, 53BP1, PCNA, RAD51 etc (127-131). Among these modifications, 
phosphorylation at Ser139 of H2AX to generate γ-H2AX is the most well-documented 
case of foci forming after IR as a result of a local modification of a chromatin bound 
protein (132,133). γ-H2AX foci form in chromatin sites adjacent to DSBs and their 
initial number decreases concomitantly with DNA DSB repair, which makes them a 
good surrogate marker for studying DSBs and their repair (134-136).  
γ-H2AX foci are conveniently detected by immunofluorescence microscopy and can 
be precisely scored by image processing, generating thus a sensitive technique for 
DSB-quantification (137-139). However, care must be taken not to equate a γ-H2AX 
focus with a DSB at all times (140). A pulsed-field gel electrophoresis (PFGE) 
method has been used to measure DSBs in mammalian cells after relative high 
doses (10–25 Gy) of ionizing radiation (141,142). Scoring of γ-H2AX foci is now 
generally accepted as an approach to evaluate of DSB repair kinetics at low radiation 
doses (135,143). Compared to PFGE and despite its weaknesses, use of γ-H2AX 
foci as a DSB marker remains a viable approach, particularly at low doses of 
radiation where PFGE can not be used (144).  
Phosphorylated ATM also forms foci in response to IR (145). Other treatments, such 
as hypotonic shock, can also activate ATM but do not lead to foci formation (146). 
The kinetics of ATM-pS1981 foci formation is comparable to that of γ-H2AX. The 
induction of ATM-pS1981 foci shows a linear dose–response relationship between 
0.1-1 Gy (147). 
Although foci formation seems to be a general observation after IR, there is only very 
limited information regarding possible connections between foci formation and the 
signal transduction pathways leading to G2 arrest. It is reported that increased 
formation of γ-H2AX foci is detected in early thymocytes of aged mice as compared 
to young mice(148). Since senescence is usually accompanied by compromised 
checkpoint activation (149,150), a linkage between foci formation and checkpoint 
activation is suggested. Other evidence suggests that γ-H2AX regulates the 53BP1 
foci formation, and that this regulation is strongly related to the levels of DNA 
damage present. Only sufficient accumulation of 53BP1 at DSB site can prevent 
entry of damaged cells into mitosis (151). 
Introduction 
 13
Persistent ATM-pS198 foci are found in the cell nucleus after IR. These persistent 
foci are lower in numbers as compared to those initially seen and display an altered 
geometry and size (152). All persistent ATM-pS1981 foci colocalize with the 
persistent foci of γ-H2AX, MDC1, 53BP1, and NBS1. Defective formation of the 
persistent IR-induced foci is observed in cells derived from AT and NBS patients, 
which are defective in the IR-induced G1 checkpoint. These results indicate that the 
development of the persistent foci plays a pivotal role in checkpoint activation 
especially during G1 arrest (152).  
2.4 Prospects of this thesis 
Checkpoint activation alters the normal distribution of cells through the cell cycle, 
which is easily detected by DNA content variation in flow cytometry. This technology 
is central to the present work. Mitotic index (MI) variation also reflects the G2 
checkpoint activation and provides even higher sensitivity than G2 phase 
accumulation assayed by flow cytometry. In some experiments, a flow cytometry 
protocol was used to quantify checkpoint activation evaluating MI and DNA content 
simultaneously.  
As tools to study interdependencies between DNA-PKcs, ATM, and ATR, extensive 
experiments were carried out using cell lines with the appropriate genetic background 
and an array of inhibitors. And the goal was to reveal the contributions of these 
kinases to the development and maintenance of the G2 checkpoint. 
Foci formation of different components from the DNA damage response machinery 
offers a unique opportunity to study of the G2-checkpoint. In the present thesis, we 
will take advantage of these facts to build a connection between foci formation for 
specific proteins and G2 checkpoint activation. This is because, the major kinases 
implicated in this cellular regulatory function, DNA-PKcs, ATM, and ATR form foci 
around DSBs, which suggests not only that they have registered the presence of this 
dangerous lesion, but also that they have proceeded with their own activation. In the 
case of ATM, autophosphorylation at Serine 1981, which suggests the activation of 
ATM, is easily detected as foci at DSB sites; Localization around DSBs of ATR, as 
can be nicely documented using its partner ATRIP, allows confirmation of its 
presence in regions of DSBs. The aspect of foci formations are extensively used here 
to study the involvements of these kinases in the G2 checkpoint.  
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For this purpose, we examined carefully, mainly in G2, the kinetics of activation of 
each of these kinases in order to obtain information regarding their kinetics of 
engagement and their sequential activation. The relevance of these observations for 
G2 checkpoint activation and the coordination of the DSB repair pathways will be 
discussed. 
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3 Materials and methods 
3.1 Cell culture 
3.1.1 Tissue culture  
Tissue culture was performed in SANYO MCO-18 O2/CO2 incubators at 37°C with 
5% CO2. A549 cells were maintained in McCoy’s 5A medium (M4892, Sigma-Aldrich) 
supplemented with 10% fetal bovine serum (FBS) (S0615, BIOCHROM). AT5-BIVA 
cells were maintained in MEM medium (61100-087, GIBCO) supplemented with 10% 
FBS. GM847-ATRkd cells were maintained in MEM supplemented with 10% FBS. 
F02-98 primary human Seckel syndrome fibroblasts were maintained in MEM 
supplemented with 15% FBS. DK0064 lymphoblast cell from human Seckel 
syndrome was maintained in suspension form in RPMI1640 (R6504, Sigma-Aldrich) 
+ 10% FBS. M059J and M059K cells were maintained in DMEM (D5523, Sigma-
Aldrich) supplemented with 10% FBS. HCT116 DNA-PKcs-/- and HCT116 wt cells 
were maintained in McCoy’s 5A medium supplemented with 10% FBS. 
Cells were grown in 100 ml tissue culture dishes (664160, CELLSTAR) with 15ml 
growth media. Exponentially growing cells were passaged every 3 days while 
avoiding confluency levels above 80%. For passage, media were removed and cells 
were rinsed with cold PBS. Cells were rinsed with by 5 ml trypsin-EDTA solution and 
incubated for 5 min at 37°C. Detached cells were resuspended in 10 ml cold media 
supplemented with 10% FBS.  Single cell suspensions were obtained by passing 
cells through the Pasteur pipette. Cells were counted and appropriate numbers of 
cells were further incubated for experiments or for subculture, see Appendix 2. When 
frozen cells were taken to subculture, they were passed at least 5 times before being 
used in experiments. Cells were discarded after about 50 passages, since their 
genomic stability could not be guaranteed. 
3.1.2 Antibody production 
ATRIP 3.51 hybridoma cells, a generous gift from Professor Thanos D. Halazonetis, 
Geneva, Switzerland, produces a monoclonal antibody which shows very high avidity 
against human ATRIP. 106/ml cells were seeded in 15 ml HSFM media (12040-077, 
Invitrogen) and were maintained in exponentially growing phase by passaging them 
Materials and methods 
 16
every 3 days. For antibody generation, 106/ml cells were incubated in the above 
growth medium for 15 days. Supernatant from these cultures was centrifuged at 4500 
RPM to remove cell debris and was passed through a 0.22 μm filter to remove 
possible contamination. Sodium azide (S2002, Sigma-Aldrich) was added to a final 
concentration at 0.02% (w/v), and supernatant was stored at -80°C until use.  
3.1.3 Drug treatments 
Caffeine (C8960 Sigma-Aldrich) was dissolved in Milli-Q water (Z00QSV001, 
Millipore, 18.2 MΩ·cm at 25°C) to prepare a 200 mM stock solution. The solution was 
sterilized by passing through a 0.22 μm filter and stored in RT. 4 mM caffeine was 
used as the working concentration. 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one 
(118500, Calbiochem, also known as KU-55933) was dissolved in DMSO (Dimethyl 
sulfoxide) (D8418, Sigma-Aldrich) to prepare a 10 mM stock solution that was stored 
at -20°C  in the dark. 10 μM was used as the working concentration. 7-
hydroxystaurosporine (539644, Calbiochem, also known as UCN-01) was dissolved 
in DMSO to prepare a 10 μM stock solution that was stored at -20°C in the dark. 100 
nM was used as the working concentration. The Chk2 inhibitor II (220486, 
Calbiochem) was dissolved in DMSO to prepare a 10 μM stock solution that was 
stored at -20°C in the dark. 400 nM was used as the working concentration. 2-
(Morpholin-4-yl)-benzo[h]chomen-4-one (N1537, Sigma-Aldrich, also known as NU-
7026) was dissolved in DMSO to prepare a 10 mM stock solution that was stored at -
20°C  in the dark. 10 μM was used as the working concentration. All drugs were 
given to the cells 1 h before irradiation and maintained during the experiment. 
Doxycycline Hyclate (D9891, Sigma-Aldrich) was dissolved in Milli-Q water to 
prepare a 5 mg/ml stock solution. The solution was sterilized by passing through a 
0.22 μm filter and stored at -20°C in the dark. 5 μg/ml was used as working 
concentration. ATRkd expression was induced by incubating the exponentially 
growing GM847-ATRkd cells in doxycycline containing media for 36 to 48 h. The 
drug was maintained in the culture during the experiment. 
3.1.4 Cell synchronization 
Cell populations enriched in G1 cells were obtained by serum deprivation. Briefly, 
0.15 million cells were seeded in 5 ml media supplemented with 10% FBS in 60 mm 
dishes. Medium was removed after 48 h. At this time, cells were in the exponential 
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phase of growth. Cells were washed twice with pre-warmed PBS and incubated in 
5ml fresh serum-free medium for 24-36 h. Subsequently, cells were transferred in 
fresh growth medium supplemented with 10% FBS for 3 h before further 
manipulations. The distribution of cells through the cell cycle was measured by flow 
cytometry (see below). At this stage, at least 90% of the cells were in G1 phase. 
Cell populations enriched in G1 or G2 cells were also obtained by a centrifugal 
elutriation. Briefly, 1 million cells were seeded in 15 ml growth media supplemented 
with 10% FBS in 100 mm dishes. At least, 40 dishes were prepared for each 
elutriation. After 48 h, cells were washed, trypsinized, suspended in the fresh growth 
medium supplemented with 10% FBS and counted. About 140 million exponentially 
growing cells could be collected for elutriation. Cells were loaded into an elutriation 
rotor (Avanti J-20 XP, BECKMAN COULTER). Fractions were collected by gradually 
reducing the rotor speed. Cell cycle analysis was carried out by flow cytometry. 
Typically, cell populations with at least 92% G1 cells were obtained in G1 fraction; 
and 75% G2 cells in G2 fraction. 
Populations enriched in mitosis were obtained by treatment with nocodazole (M1404, 
Sigma-Aldrich). Briefly, 0.15 million cells were seeded in 5ml growth media 
supplemented with 10% FBS in 60mm dish and were allowed to grow for 48 h. At this 
time, cells were growing exponentially. Medium was replaced with 5ml fresh growth 
media supplemented with 10% FBS and 0.04 μg/ml nocodazole and incubated for 
15-17 h. To release the nocodazole block, cells were washed twice with PBS and 
supplied with 5 ml pre-warmed fresh growth medium supplemented with 10% FBS. 
The cell cycle distribution was determined by flow cytometry. At least 75% cells were 
in mitosis at this stage. 
3.1.5 Pulse labeling 
BrdU and EdU are thymidine analogues that can be incorporated into DNA during DNA 
replication. They label S-phase cells with high specificity. Exponentially growing cells were 
pulsed labeled with 10 μM BrdU (B23151, Invitrogen) or 10 μM EdU (C10085, 
Invitrogen) at 37°C  for 30 min. Cells were washed twice with pre-warmed PBS and 
supplied with pre-warmed fresh growth medium supplemented with 10% FBS. Cells 
could be used for the further manipulations.  
3.2 Ionizing radiation (IR) 
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Cells were exposed to 320 kV X-rays with a 1.65 Al filter (GE-PANTAK). The dose 
rate was about 2 Gy/min. An even radiation was ensured by rotating the radiation 
table. Cells were returned to the incubator immediately after IR.  
3.3 Flow cytometry 
3.3.1 Cell cycle analysis by flow cytometry 
Propidium iodide binds to DNA proportional to its mass. Cell cycle distribution was 
assessed by measuring propidium iodide (PI) fluorescence on a flow cytometer. Cells 
were washed with cold PBS and trypsinized at 37°C for 5 min. Single cell 
suspensions were prepared in 5ml cold fresh media. About 1 million cells were 
collected and centrifuged at 1500 RPM, 4°C for 5 min. The cell pellets were washed 
with cold PBS and fixed in 70% ethanol at -20°C overnight. Supernatant was 
removed by centrifugation at 1500 RPM for 5 min. Pellets were washed with cold 
PBS and incubated in PBS containing PI (40 μg/ml) (81845, Sigma-Aldrich) and 
RNase (62 μg/ml) (R4875, Sigma-Aldrich) at 37°C  for 30 min in dark. Samples were 
measured on a flow cytometer (COULTER EPICS XL, BECKMAN COULTER) 
according to pre-established protocols, see Appendix 3. 20,000 cells per sample 
were counted and the single cell population was gated to obtain standard histograms. 
Histogram files (*.HST) were generated by counting the frequency of the cell with 
same PI signal intensity.  
The fractions of cells in the different phases of the cell cycle were calculated using 
the Wincycle® software. HST files were loaded into the Wincycle®. The parameter “S-
phase growing order” was carefully chosen between 0, 1 or 2, until the prediction 
model fitted the histogram shape. Cell cycle distributions were automatically 
calculated. G2 arrest kinetics was obtained by plotting the G2 fraction as a function of 
time after IR. 
3.3.2 Bivariate flow cytometry 
Bivariate flow cytometry was used to simultaneously measure DNA content and the 
levels of proteins of interest, e.g. phosphorylation of Histone 3 at serine 10 (H3-pS10), 
cyclin B1 and BrdU. Briefly, 0.6-0.8 million cells were prepared as single cell 
suspension in cold fresh media. After centrifugation at 1500 RPM, the cell pellets 
were washed with cold PBS and fixed in 70% ethanol at -20°C overnight. 
Materials and methods 
 19
Supernatants were removed by centrifugation at 1500 RPM for 5 min. Cells were 
further permeabilized in 2ml permeabilization solution (PBS + 0.25% Triton X-100) on 
ice for 15 min. Supernatants were removed by centrifugation at 1500 RPM and the 
pellets were washed with cold PBS. Cells were blocked in blocking buffer (PBS + 
0.05% Tween-20 + 1% BSA (8076.2, ROTH)) at RT for 45 min in the dark with gentle 
agitation. Primary antibodies, e.g. H3-pS10 (06-570, upstate) and cyclin B1 (sc-752, 
Santa Cruz), were diluted 1:150 in blocking buffer. After centrifugation at 1500 RPM 
for 5 min, the pellets were suspended in 100 µl diluted primary antibody and 
incubated for 2 h at RT in the dark with gentle agitation. The primary antibody was 
diluted in 5ml PBS and the cells were washed 3 times with PBS. Secondary 
antibodies, such as Mouse IgG-FITC (F0257, Sigma), Rabbit IgG-FITC (AP307F, 
Chemicon), were diluted in blocking buffer (1:200). Cell pellets were incubated with 
100 µl conjugated secondary antibody for 90 min at RT in dark. Secondary antibodies 
were removed by diluting in 5ml PBS and washing with PBS for three times. Cells 
were then incubated with PI plus RNase at 37°C for 30 min in the dark before 
measuring on a flow cytometer. Totally 20,000 cells were measured. Proper gating 
was applied to detect cyclin B1 positive, H3-pS10 positive cells and to calculate their 
fraction in the total population. Compensation was applied when necessary. Detailed 
information for program settings is available in Appendix 4. 
Detection of BrdU incorporation was achieved using published protocols. Briefly, 0.8-
1 M BrdU labeled cells were collected and fixed in ethanol. Cells were incubated in 2 
ml 1M HCl for 10 min at RT for DNA denaturation. Acid was diluted with 5 ml PBS 
and cells were washed 3 times with PBS. BrdU primary antibody (1:200) (B23151, 
Beckson-Dickson), secondary antibody (1:300) were diluted in blocking buffer and 
sequentially applied. Finally, the cells were stained with PI-RNase staining solution 
as described above. Totally 20,000 cells per sample were measured on flow 
cytometry. Proper gating (BrdU positive cells) was applied to analyze the measured 
cell populations. Detailed information on program setting is available in Appendix 4. 
3.4 Electrophoresis and Immunoblotting 
3.4.1 Cell extracts preparation and protein concentration determination 
Cells were collected and were washed twice with cold PBS. They were lysed for 20 
min in ice cold RIPA buffer (89900, PIERCE, 1 ml RIPA per 5 million cells) with Halt 
Phosphatase Inhibitor Cocktail (78420, PIERCE) and Halt Protease Inhibitor Cocktail 
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(78410, PIERCE). Lysates were briefly sonicated and centrifuged at 12000 RPM, 4°C  
for 10 min. Supernatants were transferred into the fresh tubes and protein 
concentration were determined using the BCA (bicinchoninic acid) protein assay (Kit 
23225, PIERCE) before aliquoting and storing at -20°C . 
3.4.2 Electrophoresis  
20 μg whole cell extract was mixed with 2x SDS-PAGE loading buffer. Samples were 
denatured at 95°C for 5 min and cooled down on ice for 5 min.  They were 
centrifuged at 3000 RPM for 15 sec before loading. SDS-PAGE mini gels were cast 
(165-8000, Mini-PROTEAN Tetra Cell, BIO-RAD) by following the instructions from 
the manufacturer. Proteins were resolved in gels with different concentrations 
according to their sizes; for example 15% gel for proteins smaller 50 KD, 12% for 
proteins between 50-100 KD, 10% for proteins between 100-200 KD, and 8% for 
proteins larger than 200 KD. Samples were loaded and run at constant voltage (150 
V) for 1.5 h at RT, see Appendix 5.  
3.4.3 Immunoblotting 
After the electrophoresis, the gels were removed from the cassette and briefly rinsed 
with MQ water. PVDF membranes (RPN303F, GE Healthcare) and the blotting paper 
(GB004 Waterman) were cut to the desired size. PVDF membranes were pre-soaked 
in 100% methanol for 1 min and rinsed in MQ water for 15 min. PVDF membranes, 
blotting paper and the transfer unit sponge were equilibrated in 1x transfer buffer 
(Glysine 200 mM (3908.2, ROTH), Tris 25 mM (4855.2 ROTH), 10% Methanol 
(32205, Sigmal-Aldrich)) at 4°C  for at least 30 min. The Gel, blotting papers, sponge 
and PVDF membrane were assembled and loaded into an electro-transfer unit (170-
3930, Mini Trans-Blot Electrophoretic Transfer Cell, BIO-RAD) according to the 
instructions from the manufacturer. Wet electro-transfers were run at 100 V, 0°C for 1 
h. Detailed information is available in Appendix 5. 
After completion of transfer, the unit was disassembled and the side of the 
membrane on which proteins were transferred was marked. PVDF membranes were 
briefly rinsed with PBST (PBS + 0.05% Tween-20) and blocked in blocking buffer 
(PBS + 0.05% Tween-20 + 5% milk (T145.2, ROTH) at RT for 1h with gentle 
agitation. Primary antibodies, for instance ATR (Ab2905, Biozol), Lamin A/C (Sc-
7292 santa cruz), ATM (GTX77613, Gene Tex), ATM-pS1981 (4526, Cell Signaling) 
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were diluted in blocking buffer 1:800, GAPDH (Mab374, CHEMION), 1:20,000, 
ATRIP (culture supernatant) (1:10). Membranes were incubated with primaries 
antibodies at 4°C overnight with gentle agitation. The secondary antibodies, such as 
mouse IgG-HRP (7076, Cell Signaling), rabbit IgG-HRP (7074, Cell Signaling) were 
diluted 1:2000 in blocking buffer. After removing primary antibodies and washing with 
PBST (3 x 10 min), membranes were incubated with secondary antibodies at RT for 
1 h. After washing with PBST (3 x 10 min), the membranes were ready for 
development. The ECL developing solution (RPN2132, GE Healthcare) was 
prepared according to the instructions from the manufacturer and evenly distributed 
on the side of the membrane on which the proteins were transferred. After 1 min 
incubation at RT in the dark, images were obtained using the molecular imager 
VersaDoc MP 4000 System (#170-8640, BIO-RAD). 
3.5 Immunofluorescence and data analysis  
3.5.1 Confocal microscopy 
Sterilized cover slips (2 mm x 2 mm, 8404, Invitrogen) were incubated in 1 mg/ml 
poly-L-lysine (L7240, Biochrom) solution for 1 h. Solution was removed and cover 
slips were stored at 4°C in the dark. Cells were plated with 2 ml growth medium in a 
35 mm dish with poly-L-lysine coated cover slips. At each time point, growth media 
were removed, cells were washed in cold PBS 3 times and fixed in 2% 
paraformaldehyde (PFA, 76240, FLUKA) for 15 min at RT. PFA was removed and 
cells were washed 3 times with PBS. Cells were permeabilized in P-solution (100 mM 
Tris pH7.4, 50 mM EDTA, 0.5% Triton X-100) for 10 min at RT. After washing 3 times 
with PBS, cells were blocking in the PBG solution (0.2% Gelatine, 0.5%BSA in PBS) 
at 4°C overnight.  
Primary antibodies, such as ATM-pS1981 (Ab2888, Abcam), ATM-pS1981 (4526, 
Cell Signaling), Chk2-pT68 (18-785-210077, BIOZOL) were diluted 1:300 in PBG, 
ATRIP (culture supernatant) was diluted 1:5 in PBG. 100 μl diluted primary 
antibodies were dispensed on parafilm (52858-032-CS, The Lab Depot, Inc.). The 
cover slips were mounted on top of the solution containing the primary antibodies. 
After incubating at RT for 2 h in the dark, slides were returned to the dishes and 
washed with PBST (PBS+0.05%Tween 20) at RT 3 x 10 min. Conjugated secondary 
antibodies, such as Alexa488 mouse IgG (A11001, Invitrogen), Alexa488 rabbit IgG 
(A11008, Invitrogen), Alexa568 mouse IgG (A11004, Invitrogen), Alexa568 rabbit IgG 
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(A11011, Invitrogen) were diluted in PBG 1:400. Slides were incubated with 100 μl 
secondary antibody solution at RT for 1 h in the dark. After 3 washes in PBST, cells 
were counterstained with 100 ng/ml DAPI (D3571, Invitrogen) at RT for 5 min. The 
cover slips were washed 3 times with PBS and mounted on slides with 15 μl Prolong 
Antifade Mounting Media (P-7481, Invitrogen). The slides were kept in the dark at RT 
and allowed to solidify for 48 h before analysis. 
Detection of EdU was performed according to a commercially available protocol, 
except for the staining sequence. Literature suggests that EdU staining should 
precede antibody-protein binding. In our experience, however, ATM-pS1981 foci 
were not detectable when following this order. EdU staining without compromising 
ATM-pS1981 foci detection could be achieved by changing the sequence and stain 
first for ATM-pS1981, then EDU and finally with DAPI. 
Scanning of the slides was carried out on a Leica SP5 confocal microscope. For 
each slide, at least 5 fields were scanned (about 300 nuclei). Resolution was set at 
512 x 512 and the zoom factor at 2. Bidirectional scans were applied to avoid 
bleaching of the fluorophore. Due to the differences in foci formation patterns, 
different proteins required different scanning parameters, such as laser intensity, 
PMT voltage, SMART GAIN offset, filter spectrum range, etc. The parameters used 
in each case are summarized in Appendix 6. LIF files were generated after each 
scan, which were used for foci quantification using the Imaris® software (see below). 
TIFF Images shown in the text were obtained from the maximum intensity projection 
of the field scanned.  
3.5.2 Foci scoring 
Foci numbers were enumerated using Imaris® (Imaris 6.0; Bitplane). At least 300 
target nuclei were scored. The LIF files were loaded to Imaris using default settings. 
“Bright dots” with a size larger than 0.5 µm and intensity above the threshold value 
(between 17–21, summarized in Appendix 6) were confirmed as foci. Foci were 
grouped in each nucleus, and the number of foci per nucleus was obtained. In some 
cases, the mean number of foci per nucleus was calculated from data obtained by 
analyzing many nuclei. For data analysis, Microsoft Excel 2003® was used. 
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4 Results 
4.1 Part 1. What is the contribution of ATM and ATR to G2 arrest? 
After exposure to IR, cells experience a delay in their progression from the G2 into 
the M-phase of the cell cycle. As discussed above, the ATM-Chk2 and the ATR-Chk1 
signaling pathways are thought to be integral to the signal transduction cascade 
underlying the development of the G2 checkpoint.  
We set out to investigate the contributions of each of these pathways in the 
generation of the overall delay experienced in G2 by human cells exposed to IR. 
Diverse mutants as indicated and inhibitors of key players of this pathway (see below) 
were used for this purpose. UCN-01 is a rather specific inhibitor of Chk1 (IC50=11 nM, 
IC50 stands for half maximal inhibitory concentration) with radiosensitizing properties 
and the ability to modulate G2 arrest (153,154). KU-55933, is a highly specific, new 
generation ATM inhibitor (IC50=13 nM) (155). Chk2 inhibitor II is used to inhibit Chk2 
kinase activity (156). Caffeine is the least specific inhibitor used in the present study, 
but it is known to inhibit both ATM as well as ATR and to exert inhibitory activity on 
DNA-PKcs as well (157). 
A549 were used as control in these experiments. A549 is a human lung carcinoma 
cell line with no known defects in DNA repair or in cell signaling, and expresses a 
wild type form of p53. The results obtained with this cell line are summarized in 
Figure 04. Exposure of A549 cells to 4 Gy X-rays causes a delay in their progression 
from the G2 into the M-phase of the cell cycle, manifest by a gradual but transient 
accumulation of cells in G2, which are easily detectable by flow cytometry. In 
irradiated cultures, the fraction of cells in G2 increases from 8% to nearly 50% 12 h 
after exposure (Figure 5A). At later times, the fraction of cells in G2 gradually 
decreases indicating that cells overcome the checkpoint and resume progression 
through the cycle.  
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Figure 4. A549 G2 arrest pattern and cell cycle distribution analysis. Exponentially growing A549 
cells were irradiated at 4 Gy. Cells were sampled every 3 h, fixed and stained with PI. PI signals were 
measured by flow cytometry. (A) Histogram of PI signal indicates the DNA content.  (B) Cell cycle 
analysis on Wincycle®. S phase cells growing order can be either selected at 0, 1, or 2.  In this case, 
“0” order prediction model fits the histogram very well. The calculations of cell cycle distributions are 
shown at the right panel. 
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Caffeine and UCN-01 are well documented to abrogate G2 checkpoint after IR 
(154,158), which are also confirmed in our experiment. The IR-induced G2 fractions 
fluctuations are dramatically reduced in presence of these drugs, (Figure 5A, 5C). 
Specific inhibition of ATM using KU-55933 delays the kinetics of accumulation in G2 
with a peak now reached at 20 h, instead of 12 h, but persisting for longer periods of 
time. However, the maximum level of G2 accumulation achieved is comparable to 
that measured in irradiated cells that were not treated with the inhibitor (Figure 5B). 
This result may hint to an early involvement of ATM in developing G2 checkpoint. 
This KU-55933 mediated alteration of G2 arrest can be counteracted by caffeine, and 
simultaneous treatment with both inhibitors causes a response practically identical to 
that of caffeine alone, compare Figure 5A, 5B and 5E.   
ATM functions in the G2 arrest by signaling to Chk2 (159). Therefore, inhibition of 
ATM or Chk2 is expected to generate similar results. Surprisingly, unlike KU-55933, 
400 nM Chk2 inhibitor II (IC50 for Chk2 = 12.5 nM) (156) does not cause a 
measurable change in the pattern of G2 arrest after exposing cells to 4 Gy (Figure 
5D). An additional experiment utilizing 800 nM of the drug also fails to demonstrate 
an effect (data not shown).  
The results in Figure 5A and 5E demonstrate that administration of caffeine at 4 mM 
prevents the IR-induced accumulation in G2 almost entirely. Since caffeine is known 
to inhibit all kinases (IC50ATM = 0.2 mM, IC50ATR = 1.1 mM, IC50DNA-pK = 10 mM) 
(157)), these  result directly indicate  the implication of ATM, ATR as well as DNA-
PKcs in the response.  
4.1.1 The Role of ATM in G2 checkpoint response 
To investigate the effect of ATM on the development of the G2 checkpoint in greater 
depth, we introduced mutants with defects in this protein. AT5-BIVA is an 
immortalized ATM mutant cell line generated by transfection of AT cells with SV40 
DNA. The large tumor antigen (TAg) encoded by this viral DNA binds p53 and Rb 
and compromises their activities (160). The distribution of cells in G2 as a function of 
time after exposure to 4 Gy is summarized in Figure 06. IR induces a gradual 
accumulation of cells in G2 that reaches a maximum after about 20 h and causes a 
persistent arrest in this phase of the cell cycle (Figure 6A). This result is similar to 
that obtained with A549 cells exposed to KU-55933 (Figure 5B) and suggests that 
genetic or chemical inactivation of ATM give equivalent results.  
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Figure 5. Multiple drugs’ effects on A549 after 
4 Gy IR. Exponentially growing A549 cells were 
pre-treated with different drugs 1 h before 4 Gy IR, 
and the drugs were maintained in the duration of 
the experiment. Cells were sampled every 3 h, 
fixed, permeabilized and stained with PI.  The PI 
signal variations were measured by flow cytometry. Cell cycle distributions are calculated. G2 fractions 
obtained are plotted against time. (A), 4 mM caffeine; (B), 10 μM KU-55933; (C), 100 nM UCN-01; (D), 
400 nM Chk2 inhibitor; (E), 4 mM Caffeine + 10 μM KU-55933. The results are from 3 repeated 
experiments. Error bar stands for standard deviation. 
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Figure 6. Multiple drugs’ effects on AT5-BIVA 
after 4 Gy IR. Exponentially growing AT5BIVA 
cells were pre-treated with different drugs 1 h 
before 4 Gy IR, and the drugs were maintained in 
the duration of the experiment. Cells were sampled every 3 h, fixed, permeabilized and stained with PI.  
The PI signal variations were measured on flow cytometry. Cell cycle distributions were calculated. G2 
fractions obtained are plotted against time. (A), 4 mM caffeine; (B), 10 μM KU-55933; (C), 100 nM 
UCN-01; (D), 400 nM Chk2 inhibitor; (E), 4 mM Caffeine + 10 μM KU-55933. The results are from 3 
repeated experiments. Error bar stands for standard deviation. 
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The strong G2 arrest observation confirms the limited role of ATM in the development 
of the G2 checkpoint and is in line with the complete lack of effect observed in cells 
exposed to the Chk2 inhibitor. Not surprisingly KU-55933 remains inactive in these 
cells (Figure 6B), which provides a useful negative control since it demonstrates that 
the inhibitor has no detectable side effects. Notably, exposure of AT5-BIVA cells to 
caffeine causes a dramatic reduction in the accumulation of cells in G2 (Figure 6A) in 
line again with a contribution of ATR or DNA-PKcs in the development of the G2 
checkpoint in ATM cells. Similar results are obtained after treatment with UCN-01 
(Figure 6C), once again confirming the contribution of ATR/Chk1 signaling in the 
overall response. 
4.1.2 The Role of DNA-PKcs in G2 checkpoint response 
Although caffeine inhibits the functions of DNA-PKcs when tested in vitro (161), the in 
vivo effects of the drug are not compatible with inhibition of this kinase at 
physiological conditions. Thus, inhibition of DNA-PKcs by genetic or chemical means 
has a strong effect on the ability of cells to repair DSBs by NHEJ (162-164). On the 
other hand, treatment of cells with caffeine at the concentration typically used in such 
experiments (up to 10 mM) has no measurable effect on DSB rejoining (161). Thus, 
the in vitro inhibition by caffeine of DNA-PKcs may not be relevant for the actual 
signaling activity of DNA-PKcs (163), a conclusion that is also compatible with the 
IC50 for this kinase (10mM).  
To explore the contribution of DNA-PKcs to the prolonged G2, M059J and M059K 
cells were used. M059J is human glioma mutant defective in DNA-PKcs. M059K, 
with  competent DNA-PKcs, is used as a wild type counterpart (165). NU-7026 is a 
specific competitive inhibitor of DNA-PKcs (IC50=0.23 μm) (166,167). By addition of 
NU-7026, DNA-PKcs can be inactivated in M059K. 
As it is shown in summarized results, M059K cells show a transient G2 arrest after 
exposing to 2 Gy, which can be completely abrogated by 4 mM caffeine (Figure 7A). 
Inhibition of ATM with KU-55933 has a similar effect to that observed in A549 cells 
(Figure 7B). Significantly, inhibition of DNA-PKcs with NU-7026 also generates a 
significantly stronger and more persistent G2 arrest that is comparable to that 
measured after ATM inhibition, particularly when considering that in these 
experiments 2 Gy instead of 4 Gy IR were used (Figure 7C).   
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Figure 7. Multiple drugs’ effects on M059J and M059K G2 arrest after 2 Gy IR. Exponentially 
growing M059J and M059K cells were pre-treated with different drugs 1 h before 2 Gy IR, and the 
drugs were maintained in the duration of the experiment.. Cell cycle distributions were calculated. G2 
fractions are plotted against time. (A) M059K treated with 4 mM caffeine; (B) M059K treated with 10 
μM KU-55933; (C) M059K treated with 20 μM NU-7026; (D) M059J treated with 4 mM caffeine; (E) 
M059J treated with 10 μM KU-55933; (F) M059J treated with 20 μM NU-7026. The results are from 3 
repeated experiments. Error bar stands for standard deviation. 
Results                                                                            
 30
A D
C 
E
F
Time after IR [h]
0 5 10 15 20 25 30 35
G
2 
pe
rc
en
ta
ge
10
20
30
40
2Gy
0Gy 
2Gy+NU7026
0Gy+NU7026
HCT116 DNA-PKcs-/-
+ 20 μM NU-7026 
B 
Time after IR [h]
0 5 10 15 20 25 30
G
2 
pe
rc
en
ta
ge
10
20
30
40
2Gy
0Gy 
2Gy+KU55933
0Gy+KU55933
HCT116 wt 
 + 10 μM KU-55933
Time after IR [h]
0 5 10 15 20 25 30
G
2 
pe
rc
en
ta
ge
10
20
30
40
2Gy
0Gy 
2Gy+Caffeine
0Gy+Caffeine
HCT116 wt 
 + 4 mM Caffeine
Time after IR [h]
0 5 10 15 20 25 30 35
G
2 
pe
rc
en
ta
ge
10
20
30
40
2Gy
0Gy 
2Gy+Caffeine
0Gy+Caffeine
Time after IR [h]
0 5 10 15 20 25 30 35
G
2 
pe
rc
en
ta
ge
10
20
30
40
50
2Gy
0Gy 
2Gy+KU55933
0Gy+KU55933
Time after IR [h]
0 5 10 15 20 25 30
G
2 
pe
rc
en
ta
ge
10
20
30
40
2Gy
0Gy 
2Gy+NU7026
0Gy+NU7026
HCT116 wt 
+ 20 μM NU-7026
HCT116 DNA-PKcs-/-
 + 10 μM KU-55933 
HCT116 DNA-PKcs-/-
 + 4 mM Caffeine 
 
 
 
Figure 8. Multiple drugs’ effects on HCT116 DNA-PKcs-/- and HCT116 wt G2 arrest after 2 Gy IR. 
Exponentially growing DNA-PKcs-/- and HCT116 wt cells were pre-treated with different drugs 1 h 
before 2 Gy IR, and the drugs were maintained in the duration of experiment. Cells were sampled 
every 3 h, fixed, permeabilized and stained with PI.  The PI signal variations were measured on flow 
cytometry. Cell cycle distributions were calculated. G2 fractions obtained are plotted as a function of 
time. (A) HCT116 DNA-PKcs-/- treated with 4 mM caffeine; (B) HCT116 DNA-PKcs-/- treated with 10 
μM KU-55933; (C) HCT116 DNA-PKcs-/- treated with 20 μM NU-7026; (D) HCT116 wt treated with 4 
mM caffeine; (E) HCT116 wt treated with 10 μM KU-55933; (F) HCT116 wt treated with 20 μM NU-
7026. The results are from 3 repeated experiments. Error bar stands for standard deviation. 
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This observation is further confirmed in M059J cells (Figure 7D) that shows a large 
increase in G2 arrest, as compared to M059K cells, which remains caffeine sensitive. 
Interestingly, in M059J cells, inhibition of ATM with KU-55933 has no further effect on 
G2 arrest suggesting that inhibition of ATM and DNA-PKcs leads to equivalent 
responses (Figure 7E). As expected, NU-7026 has no further effect on M059J cells 
(Figure 7F). The slightly smaller effect of NU-7026 on M059K cells compared to 
M059J cells tested in the absence of this drug may be due, either to incomplete 
inhibition of DNA-PKcs, or to drug inactivation at later incubation times.  
We further performed a similar experiment by using HCT116 cells system, in which 
DNA-PKcs knockout mutant has been generated. The results shown in Figure 8 
demonstrate that practically identical responses can be obtained. The ATM level is 
reported very low in M059J cells (168,169). A recent measurement in our laboratory 
indicates that HCT116 DNA-PKcs-/- cells also show low ATM levels. The observed 
long persistent G2 arrest might be also triggered by ATM, which may bias the results 
obtained. If it is true, it may suggest that there is a coupling between ATM and DNA-
PKcs levels relevant to the responses investigated here.  
4.1.3 The Role of ATR in G2 checkpoint response 
Overall the above experiments leave ATR as the prime candidate kinase responsible 
for the development and maintenance of the G2 checkpoint, especially when ATM or 
DNA-PKcs are inactivated. In agreement with this postulate, inhibition of the down 
stream effectors of ATR, Chk1, using UCN-01 has an effect on the development of 
the G2 checkpoint in A549 cells that is quantitatively similar to that observed in cells 
treated with caffeine (compare results in Figure 5A, 5C). On the other hand, 200 nM 
of the Chk2 inhibitor II (IC50 for Chk2 = 12.5 nM) (156) has no effect on the 
development of the G2 checkpoint in A549 cells in agreement with the limited role of 
ATM in the response (Figure 5D). Increasing the concentration of this inhibitor to 800 
nM did not alter the results, thus ruling out indirectly low concentration as the cause 
for the lack of an effect. Combined treatment with caffeine and KU-55933 (Figure 5E) 
gives results identical to caffeine alone suggesting that either caffeine completely 
inhibits ATM at the concentrations used so that KU-55933 is unable to add anything, 
and/or that ATM contributes less to the development of the G2 checkpoint. 
Although the above results clearly point to a strong contribution of ATR to the 
development of the G2 checkpoint, all key conclusions are based on results obtained 
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with caffeine, a drug with pleiotropic effects. A powerful genetic system provides 
further evidence for the contribution of ATR in G2 checkpoint response. Since ATR 
inactivation is lethal in mammalian cells, only conditional inactivation generates 
useful model systems. In the GM847-ATRkd model, a Tet-on promoter is used to 
regulate the expression of exogenous ATR fragment in which kinase domain is 
inactivated (ATRkd). Administration of the tetracycline analog doxycycline in GM847-
ATRkd cells causes the overexpression of ATRkd, which competes with the 
endogenous ATR and exerts a dominant negative effect (170).  
The results in Figure 9 indicate that in the absence of doxycycline, GM847-ATRkd 
cells show a pattern of G2 arrest that is similar to that of A549, M059K and HCT116 
wt cells (See Figure 9). Thus, inhibition of ATM causes a slightly delayed but overall 
stronger blockage in G2, and the Chk2 inhibitor remains ineffective. On the other 
hand caffeine and UCN-01 cause a nearly complete abrogation of the G2 arrest.  
Addition of doxycycline for 48 h causes a strong induction of ATRkd, clearly 
demonstrated following Western blot analysis (Figure 10F). Notably, under these 
conditions no measurable arrest in G2 is measured (Figure 10A) and treatment with 
the entire collection of inhibitors including caffeine produces little additional effect 
(Figures 10A to 10E). This result strongly supports the contention that ATR is the key 
kinase initiating/maintaining the G2 arrest.  
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Figure 9. Multiple drugs’ effects on GM847 ATRkd after 4Gy IR. Exponentially growing GM847 
ATRkd cells were pre-treated with different drugs 1 h before 4 Gy IR, and the drugs were maintained 
in the duration of experiment. Cells were sampled every 3 h, fixed, permeabilized and stained with PI.  
The PI signal variations were measured on flow cytometry. Cell cycle distributions were calculated. G2 
fractions are plotted as a function of time. (A), 4 mM caffeine; (B), 10 μM KU-55933; (C), 100 nM 
UCN-01; (D), 400 nM Chk2 inhibitor; (E), 4 mM Caffeine + 10 μM KU-55933). The results are from 3 
repeated experiments. Error bar stands for standard deviation. 
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Figure 10. Multiple drugs’ effects on GM847 
ATRkd G2 arrest after 4 Gy IR in presence of 
doxycycline. Exponentially growing GM847 
ATRkd cells were treated with 5 μg/ml doxycycline for 48 h. After induction, cells were pre-treated with 
different drugs 1 h before 4 Gy IR, and the drugs were maintained in the duration of experiment. Cells 
were sampled every 3 h, fixed, permeabilized and stained with PI.  The PI signal variations were 
measured on flow cytometry. Cell cycle distributions were calculated. G2 fractions are plotted as a 
function of time. (A), 4 mM caffeine; (B), 10 μM KU-55933; (C), 100 nM, UCN-01; (D), 400 nM Chk2 
inhibitor; (E), 4 mM Caffeine + 10 μM KU-55933). The results are from 3 repeated experiments. Error 
bar stands for standard deviation. A blue line shown in each graph is the G2 arrest response without 
doxyline treatment. (F), ATR expression level before and after induction. Western blot results 
suggested the expression of ATR were significantly increased after the induction by doxycycline. 
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4.1.4 The contribution of ATM, ATR and DNA-PKcs to G2 arrest 
The relatively small contribution of ATM to the development of G2 checkpoint raises 
the question of possible artifacts in the above described experiments. In the results 
reported above, the G2 fraction was calculated by flow cytometry and the signal in 
the histogram attributed to G2 cells could also include mitotic and tetraploid cells, i.e. 
cells that are beyond the G2 arrest point. To address this limitation we searched for 
markers allowing the unequivocal identification of G2 cells.  
At the beginning of mitosis, MPF is disrupted through ubiquitin-mediated degradation 
of cyclin B1 that is synthesized in high amounts starting at about the middle of S-
phase and peaking during G2. Cyclin B1 can therefore be used as a rather specific 
G2 marker. Bivariate (DNA/cyclin B) analysis by flow cytometry of A549 and ATM 
deficient cells exposed to 4 Gy X-rays is shown in Figure 11. It is evident that even 
when the analysis is restricted to cyclin B positive cells and thus to true G2 cells, 
results similar to those discussed above are obtained.  
The delayed G2 accumulation of irradiated ATM deficient cells probably reflects the 
combined effect of G2 cell division due to checkpoint abrogation, together with the 
subsequent accumulation in G2 of cells irradiated in G1 or S phase of the cell cycle. 
To address this possibility, we followed the accumulation in G2 of cells irradiated 
during the S-phase. 5-bromo-2´-deoxyuridine (BrdU), a thymidine analog, is widely 
used to pulse-label S-phase cells (171). By following the movement of the BrdU 
signal at different times after pulse-labeling, we confirmed that BrdU positive AT cells 
are arrested after IR in the G2-phase for relatively longer periods of time - as was 
also seen in the experiments described above. These results are summarized in 
Figure 12.  
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Figure 11.Cyclin B1 as a maker of G2 cells. Exponentially growing A549 and AT5-BIVA were treated 
with 10 μM KU-55933 followed by 4 Gy IR. Samples were taken every 3 h, fixed, permeabilized and 
stained with anti-cyclin B1 antibody and PI. Cyclin B1 positive fractions were gated and calculated. 
Bivariate flow cytometry was used to detect cyclin B1 expression level (FITC) and DNA content (PI) 
simultaneously. (A) A density plot of bivariate FACS. Gated populations indicate the cells expressing 
cyclin B1. (B), Cell cycle distributions of the sample A. (C), Cyclin B1 positive fractions are plotted as 
function of time .The results are from 3 repeated experiments. Error bar stands for standard deviation. 
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Figure 12. AT5-BIVA cells Irradiated during S-phase arrest in G2 for a longer duration 
compared to wild-type control.  Exponentially growing A549 and AT5-BIVA  cells were pulse 
labelled with10 μm BrdU for 30 min. BrdU were removed immediately after 4 Gy IR and cells were 
returned to the incubator. Cells were sampled every 3 h, fixed, permeabilized and stained with anti 
BrdU antibody and PI. Bivariate flow cytometry was used to detect the BrdU signal and the DNA 
content simultaneously. Gated populations are BrdU positive cells. Density dot plot is used to group 
cells with the same fluorescence density signals. Blue: low frequency; red: high frequency.  Histogram 
is used to show the cell cycle distributions of BrdU positive cells. (A), The transition of BrdU labeled 
A549 cells in the cell cycle.   (B), The transition of BrdU labeled AT5-BIVA cells in the cell cycle. 
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Thus, although ATM deficient cells irradiated in G2 may have defective activation of 
the G2 checkpoint (172), activation of the G2 checkpoint is possible in cells irradiated 
in preceding phases of the cell cycle, such as S and G1. The different response of 
ATM deficient cells regarding G2 checkpoint activation has led to the hypothesis that 
two forms of G2 checkpoint can be distinguished depending upon where in the cell 
cycle cells are irradiated (172). We wished to investigate further this possibility and 
employed for this purpose phosphorylation of histone H3 at Serine 10 (H3-pS10) as a 
marker (3). H3-pS10 is highly phosphorylated during M-phase and allows the easy 
discrimination by flow cytometry between G2 and M-cells. The results obtained are 
summarized in Figure 13. Under normal growth conditions the mitotic population 
remains stable according to bivariate (DNA/H3-pS10) flow cytometry analysis. Figure 
13A shows the basis of discrimination of the mitotic cells according to this form of 
analysis. Figure 13B is a typical dot plot from flow cytometry which displays DNA 
content and H3-pS10 signal, as well as the gating used to identify mitotic cells. 
 
 
Figure 13. Detect mitotic cells by measuring phosphorylation of Histone3 at Serine 10. 
Exponentially growing A549 cells were fixed, permeabilized and stained anti H3-pS10, ATM-pS1981 
antibodies and DAPI. Cells were visualized by confocal microscope. (A), Confocal image of stained 
mitotic cell. (Bar = 10 µm). Cells were fixed, permeabilized and stained an anti H3-pS10 antibody and 
PI. Bivariate flow cytometry was used to detect the H3-pS10 expression level and the DNA content 
simultaneously. MI was calculated by gating H3-pS10 positive fractions. (B), H3-pS10 expression 
levels in A549 cells.  
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Figure 14. Mitotic index variations of A549 and AT5-BIVA, M059J, M059K HCT116 DNA-PKcs-/- 
and HCT116 wt in response to IR. Exponentially growing A549 and AT5-BIVA cells were pre-treated 
with KU-55933 1 h before 4 Gy IR. Exponentially growing M059J, M059K, HCT116 DNA-PKcs-/- and 
HCT116 wt cells were pre-treated with KU55933 1 h before 2 Gy IR.  Cells were incubated with the 
drugs in the duration of the experiment. Cells were sampled at each time point, fixed, permeabilized 
and stained anti Histone 3- pSer10 antibody and PI.  Bivariate flow cytometry was used to detect the 
H3-pS10 expression level and the DNA content simultaneously. Mitotic indexes are calculated by 
gating H3-pS10 positive fractions. MI was normalized by diving the MI of irradiated cells against non-
irradiated cells. Normalized MI is plotted as a function of time. (A), Mitotic index variation of A549 cells 
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after IR.  (B), Mitotic index variation of AT5-BIVA cells after IR. (C), Mitotic index variation of M059K 
cells after IR.  (D), Mitotic index variation of M059J cells after IR.  (E), Mitotic index variation of 
HCT116 wt cells after IR.  (F), Mitotic index variation of HCT116 DNA-PKcs-/- cells after IR.  The 
results are from 3 repeated experiments. Error bar stands for standard deviation. 
 
Figure 14A summarizes the development of the mitotic index (MI) in A549 exposed to 
4 Gy IR. The precipitous drop of MI within 1-2 h after IR is in line with a strong G2 
arrest in cells irradiated in G2; it starts recovering 6-8 h later and reaches control 
levels 12 h after IR. This block in G2 is abrogated after treatment with KU-55933 
implying the function of ATM in its development. Indeed, AT5-BIVA cells show no 
evidence for a drop in MI after IR and this effect is not further modified by KU-55933 
(Figure 14B). The G2 arrest appears well active in DNA-PKcs deficient M059J cells 
(Figure 14D), as compared to their wild type counterpart (Figure 14C), and in both 
cases it is abrogated by the ATM inhibitor. Similar results are obtained with HCT116 
model system (Figure 14E and 14F). In all these cases DNA-PKcs deficiency causes 
a prolonged drop in MI. These results suggest a strong dependence on ATM and 
minor dependence on DNA-PKcs of the initial development of the G2 arrest. 
However, they also suggest an involvement of DNA-PKcs in the recovery from the 
G2 arrest, as it was also described in experiment outlined above.  
While the above results reproduce salient features of the ATM response in G2, they 
also raise a number of relevant questions. For instance, in AT cells MI has been the 
recovered to basal level from 15-24 h after IR, which is apparently contradicted to the 
observed strong G2 arrest. Such a controversy can be resolved if one considers that 
the MI (about 3%, data not shown) at the zero time point, which stems from the about 
12-15% fraction of cells in G2 at that time. However, the same 3% MI at 15 h stems 
from an over 50% fraction of cells present in G2 at that time. Therefore, a significant 
reduction of G2 cells moving into M by a factor of three is observed, which suggests 
strong G2 arrest. To account for this perturbation from the variation of cell cycle, we 
calculated a MI normalized to the fraction of cells in G2 at any given time point. The 
results obtained are summarized in Figure 15. It is evident from the results that a 
clear reduction after later times in the normalized MI is observed in wild type cells 
treated with the ATM inhibitor, as well as ATM deficient cells. This observation 
reconciles the results obtained using G2 fraction analysis to those obtained using MI 
index analysis.  
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Figure 15. Normalized MI of A549 and AT5-BIVA in response to IR. The same experiment as in 
Figure 12. The MI was normalized by diving MI against G2 fraction. (A), Normalized MI of A549 after 
IR; (B), Normalized MI of AT5-BIVA after IR. The results are from 3 repeated experiments. Error bar 
stands for standard deviation. 
 
But does ATM alone, instead of ATR, contribute the effect observed on MI? To 
address this question, we performed a similar analysis in GM847-ATRkd cells. The 
results in Figure 16 demonstrate that in the absence of doxycycline, when ATR is still 
active, these cells respond to IR in a manner comparable to that of A549 cells. MI 
drops to zero 2 h after IR and recovers 6-8h later (Figure 16A). The faster response 
of these cells when compared to A549 cells is partly explained by their higher 
constitutive MI, which suggests more active growth. This reduction in MI is 
significantly reduced after inhibition of ATM using KU-55933. However, after 
compromising ATR by treatment of the cells with doxycycline, the MI remains 
relatively unchanged after IR and is not further affected by the ATM inhibitor (Figure 
16B). The same results were observed if we disrupted ATR function by caffeine 
treatment in many different genetic backgrounds (Figure 16C). 
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Figure 16. Mitotic index variations of GM847-ATRkd with or without doxycycline. Exponentially 
growing GM847 ATRkd cells with or without induction of doxycycline were pre-treated with KU-55933 
1 h before 2 Gy IR. The drugs were kept for the duration of the experiment. MI is normalized by diving 
the MI from untreated samples. Normalized MI is plotted as a function of time. (A), Mitotic index 
variation of GM847 ATRkd cells in the absence of doxycycline.  (B), Mitotic index variation of GM847 
ATRkd cells in the presence of doxycycline.  (C), Caffeine abrogated MI variation after 2 Gy IR. 
Exponentially growing A549, AT5-BIVA, M059J, M059K, HCT116wt, HCT16DNA-PKcs-/- and GM847 
ATRkd were pre-treated with 4 mM caffeine for 1 h before IR. The results are from 3 repeated 
experiments. Error bar stands for standard deviation. 
 
The persistently high levels of mitotic index in AT5-BIVA cells after IR opened the 
possibility that ATBIVA cells are blocked in M-phase of the cell cycle. Although no 
delays in M-phase have been observed in wild type cells exposed to IR, we wished to 
rule possible effects in the various mutants. For this purpose, we treated A549 and 
AT5-BIVA cells for 17 h with a highly specific inhibitor of microtubules polymerization, 
nocodazole, to generate a population of highly enriched M-phase cells. The results 
shown in Figure 17 confirmed such accumulation in M using bivariate staining with 
propidium iodide and H3-pS10 both for A549, as well as for AT5-BIVA cells. The 
synchronized cells were then exposed to either 0 or 4 Gy X-rays and their 
progression through the cycle was examined by following mitotic index as a function 
of time. There is no IR induced delay in A549 cells with more than 80% of the cells 
dividing within about 2 h. In AT5-BIVA cells, there is no radiation induced delay in cell 
division, but cell division overall is much slower than in the wild type A549 cells. Thus, 
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although ATM deficiency affects the release of cells from a nocodazole block, it does 
not alter the radiation response towards this end point. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Mitotic index variation after releasing cells from nocodazole block. Exponentially 
growing A549 and AT5-BIVA cells were synchronized at M-phase by nocodazole (0.04 μg/ml) for 17 h. 
Cells were released from the block by washing with PBS and supplied with fresh media. After 4 Gy IR 
(if applied), cells were returned to the incubator. Samples were taken at different time; thereafter the 
MI was measured by flow cytometry. Histograms indicate the cell cycle distribution after 
synchronization. H3-pS10 positive populations are gated in the red square. Each MI is normalized by 
diving against the initial MI. The normalized MI is plotted as a function of time.  
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4.2 Part 2 How does ATM help to maintain the G2 arrest? 
4.2.1 ATM, Chk2 and H2AX phosphorylation are early events in radiation 
response 
In A549 cells exposed to 2 Gy and analyzed 1 h later, ATM-pS1981, Chk2-pT68 and 
γ-H2AX show rapid foci formation. Discrete foci can be detected 5 min post IR. The 
number and intensity of observed foci reaches a maximum 30-60 min after IR (Figure 
18). Detailed analysis indicates that all Chk2-pT68 foci coincide with ATM-pS1981 
foci and that such colocalization only occurs for a short period of time due to the 
rapid decay of Chk2-pT68 foci. There is also a high level of colocalization between 
ATM-pS1981 and γ-H2AX foci. As expected, there is no ATM-pS1981 foci formation 
after IR in AT5-BIVA cells, and as a result no Chk2-pT68 foci are forming either, 
which is in agreement with the epistatic nature of ATM over Chk2 (Figure 18C). 
Although γ-H2AX foci formation is not observed 5 min after IR in AT cells, they form 
robustly after 30 min.  
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Figure18. Foci formation of different proteins. Exponentially growing A549 and AT5-BIVA were 
exposed to 2 Gy IR. After desired time, cells were fixed, permeabilized and stained with anti ATM-
pS1981, Chk2-pT68 and γ-H2AX antibodies, respectively. Images were obtained using a confocal 
microscope. (A); ATM-pS1981 and γ-H2AX foci formation in A549 cells. (B); ATM-pS1981 and Chk2-
pT68 foci formation in A549 cells. (C); ATM-pS1981, Chk2-pT68 and γH2AX foci formation in AT5-
BIVA cells. (bar = 10μm) 
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4.2.2 ATM-pS1981 and Chk2-pT68 foci formation is independent from ATR 
function 
The results of the previous section indicate important mechanistic connections 
between signaling pathways using different kinase inhibitors. We were therefore 
interested in investigating the effect of the same inhibitors on foci formation. The 
results shown in Figure 19A indicate that caffeine and UCN-01 do not modify 
detectably the formation of ATM-pS1981 foci in A549 cells exposed to IR. Neither 
foci intensity, nor foci number are affected following treatment with up to 4 mM 
caffeine and with up to 100 µM UCN-01. As expected, KU-55933 completely 
abrogates ATM-pS1981 and Chk2-pT68 foci formation. Interestingly, Chk2 inhibition 
leaves both the ATM-pS1981 and the Chk2-pT68 foci intact, which suggests that the 
inhibitor may not function, or that Chk2 activity is not required for foci formation. The 
above conclusions are also corroborated by the western blot analysis results 
summarized in Figure 19B, C. 
As shown above, caffeine does not affect the formation of ATM-pS1981 and Chk2-
pT68 foci after exposure to IR. Since we postulate that caffeine exerts its action by 
inhibiting ATR, we hypothesized that ATM-pS1981 and Chk2-pT68 foci formation are 
independent from ATR function. As discussed above, ATR knockout is lethal in 
higher eukaryotes, and therefore there is no clean system to study ATM functions in 
the absence of ATR. The GM847-ATRkd cell system used above contains 
endogenous ATRwt in parallel with the induced ATRkd after addition of doxycycline. 
Although IR induced ATM-pS1981 foci formation in GM847-ATRkd cells (in presence 
of 5 μg/ml doxycycline) is found intact (data not shown), we could not rule out the 
possibility that the endogenous ATRwt functions in a limited way and generates this 
result. Therefore we searched for alternative genetic systems to test this hypothesis.  
Individuals suffering from the Seckel syndrome, a microcephalic primordial dwarfism 
syndrome, can survive but have a hypomorphic mutation in ATR that compromises, 
without completely abrogating, the activity of the protein (94). Cells from Seckel 
syndrome patients have impaired ATR signaling and show a compromised G2 arrest 
after exposure to IR (94). F02-98 and DK0064 are cells derived from the ATR-Seckel 
patients (94,122). Interestingly, both cell lines show comparable ATM-pS1981 and 
Chk2-pT68 foci formation. These results are summarized in Figure 20 and indicate 
that ATM-pS1981 foci formation occurs in the absence of fully active ATR. This foci 
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Figure 19 Effects on of different kinase inhibitors on the phosphorylation of ATM at serine 1981 
and the phosphorylation of Chk2 at threonine 68 foci in A549 cells after IR. Exponentially 
growing A549 cells were pretreated with 4 mM caffeine, 100 nM UCN-01, 400 nM chk2 inhibitor, 10 
μM KU-55933, respectively, 1 h before IR. After 30 min, the cells were fixed, permeabilized and 
stained with anti ATM-pS1981, and Chk2-pT68 antibodies. The inhibitors effects were also checked by 
western blot. (A), Drugs effects on foci formation. (bar = 10 μm) (B), Western blot to detect drugs 
effects on the phosphorylation of ATM at S1981. (C), Western blot to detect drugs effects on the 
phosphorylation of Chk2 at T68. 
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Figure 20. ATM-pS981 and Chk2-pT68 formation in Seckel syndrome cells. Exponentially F02-98 
and growing DK0064 were irradiated at 2 Gy. After 30 min, the cell were fixed, permeabilized and co-
stained with anti ATM-pS1981, Chk2-pT68 antibodies Images were obtained from the confocal 
microscope. (A), ATM-pS981 and Chk2-pT68 formation in F02-98 cell. (B), ATM-pS981 and Chk2-
pT68 formation in DK0064 cell. (bar = 10 μm). DK0064 are suspension growing cells. They could 
not grow on the slides. After IR, the polylysine coated cover slip was put into the dish. The dish 
was centrifuged at 1500 RPM 4°C for 5 min.  Once the cells attached to the slip, the standard 
protocol for slides preparation could be followed.  
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Unlike ATM-pS1981 and Chk2-pT68, discrete ATR foci, or Chk1-pS345 foci, could 
not be detected up to 3 h after IR in A549 cells. Although we could not find discrete 
ATR foci in our experiments with the staining protocols employed, some papers 
indeed demonstrated that ATR foci can form 4-6 h after IR (16,173,174). Since ATR 
is nearly constitutively present in the cell in the form of an heterodimer with ATRIP 
(175), ATRIP foci formation was used as a substitution to study ATR localization in 
the nucleus after IR.  
As the results in Figure 21 indicate, ATRIP foci formation is a relatively slow process, 
when compared to ATM-pS1981 and γ-H2AX foci formation, and discrete foci are 
visible only about 1 h after IR. The number of ATRIP foci reaches a maximum 3-6 h 
after IR. Furthermore, ATRIP foci are found nearly exclusively in cyclin B1 positive 
cells, which corresponds to late S or G2-phase cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. ATRIP foci in irradiated A549 cells.  Exponentially growing A549 cells were irradiated at 
2 Gy. After desired time, cells were fixed, permeabilized and co-immunostained with anti ATRIP and 
cyclin B1 antibodies. Green: ATRIP; Red: Cyclin B1; Blue: DAPI. (bar = 10 μm). 
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4.2.3 Distinct differences in the kinetics of ATM-pS1981, Chk2-pT68, and 
ATRIP foci formation 
ATM and ATR both play central roles in IR induced G2 arrest as we described in the 
previous section. To compare the kinetics of G2 checkpoint activation with those of 
foci formation, we scored in A549 cells ATM-pS1981, Chk2-pT68 and ATRIP foci at 
different times after exposure to 2 Gy IR. The results are summarized in Figure 22. In 
agreement with results shown above, ATM-pS1981 foci formation after IR and 
remain rather stable in numbers for about 1 h (Figure 22A). After reaching this 
maximum, foci numbers start decaying with a half time of about 4 h. The foci number 
drops to the background level 12 h after IR. Chk2-pT68 foci form as rapidly as those 
of ATM-pS1981 but decay much sooner and no foci are detectable 4 h after IR 
(Figure 22B). In contrast to the fast kinetics of ATM-pS1981 and Chk2-pT68 foci 
formation, ATRIP foci form slower. As the results in Figure 22C indicate, foci 
formation reaches a maximum at about 1 h and remains constant for about 2 h.  
Although ATR plays a dominant role in G2 checkpoint signaling, its activation for G2 
arrest may not coincide with foci formation since visible foci form relatively late (1 h 
after IR). Such a time frame is too slow for checkpoint activation. Instead of foci 
formation, ATR may regulate G2 arrest in a different manner that remains to be 
elucidated. A possible expiation to this fact is that ATR-Chk1 pathway dominates G2 
checkpoint after ATM-Chk2 pathway is fully activated. Together these results suggest 
a cooperation between ATM and ATR for the development and the maintenance of 
the G2 checkpoint that is in line with the cross-talk between the two kinases reviewed 
in the Introduction. Since ATM remains active for a long duration even after ATR is 
fully activated, it might still exert in regulating G2 checkpoint. We hypothesized that 
their existed a connection between the persistency of ATM-pS1981 foci and G2 
checkpoint maintain. 
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Figure 22. ATM-pS1981, Chk2-pT68 and ATRIP foci kinetics in irradiated A549 cells.  
Exponentially growing A549 cells were exposed to 2 Gy IR. At each time point, cells were collected, 
fixed, permeabilized and immunostained with anti ATM-pS1981, Chk2-pT68 or ATRIP antibodies, 
respectively. Foci numbers were scored. The mean foci number in each nucleus was calculated and 
plotted as a function of time. (A), ATM-pS1981 foci kinetics; (B), Chk2-pT68 foci kinetics; (C), ATRIP 
foci kinetics. The results are from 3 repeated experiments. Error bar stands for standard deviation. 
 
4.2.4 ATM-pS1981 foci numbers are IR-dose and cell-cycle-phase dependent 
As shown in Figure 23 a linear increase in ATM-pS1981 foci is found in A549 cells 
after exposure to different IR doses (0-4 Gy) in the exponential phase of growth. A 
similar pattern is also found when scoring γ-H2AX foci (143). Three categories of 
nuclei can be identified based on the number of foci scored in these experiments: 
nuclei with low numbers of foci, nuclei with large numbers of foci, and nuclei whose 
foci numbers are between these two extremes. Careful quantitative analysis hints 
that this variation might reflect differences in DNA content for cells irradiated in the 
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various phases of the cell cycle. Thus, the same radiation dose should generate 
twice the number of foci in a G2 as compared to a G1 cell, while S cells should lie in 
between.  
To test this hypothesis, we scored ATM-pS1981 foci in synchronized G1 cells 
obtained by serum deprivation. Under these conditions, 1 Gy IR generates about 24-
27 foci in G1- phase cells (Figure 23). This number is similar to that obtained for γ-
H2AX foci (135). The dose response curves can not be extended above 4 Gy 
because above 100 foci per nucleus foci overlap causes an underestimation in the 
numbers of foci scored. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. ATM-pS1981 foci dose response in A549 cells. Cells were exposed to IR, either in 
exponential phase of growing or synchronized at G1 by serum deprivation. After 1 h, cells were 
harvested, fixed, permeabilized and immunostained with anti ATM-pS1981 antibody. ATM-pS1981 foci 
numbers were scored. The mean foci number per nucleus is plotted as a function of dose. Inserted 
histogram together with cell cycle analysis is to show the cell cycle distributions before IR. The results 
are from 3 repeated experiments. Error bar stands for standard deviation. 
 
The global G2 arrest is observed when exponentially growing cells are exposed to IR. 
Cells irradiated in G1, S and G2-phase may all progress through the cell cycle until 
they reach a specific checkpoint in G2. Therefore, for a complete analysis of the G2 
checkpoint, it is necessary to consider the origin of cells eventually arrested in G2. 
Furthermore, when exploring the connection between foci kinetics and G2 arrest, it is 
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particular important to clearly discriminate between cells irradiated in the different 
phases of the cell cycle. This is not only because the mechanism underlying G2 
arrest may be different, but also because the initial foci numbers will be different by 
as much as a factor of two.  
4.2.5 ATM-pS1981 kinetics in irradiated G1 cells 
For exponentially growing A549 cells, enriched populations of G1 cells was obtained 
by using serum deprivation, or by applying centrifugal elutriation to select highly 
enriched G1 fractions. The results in Figure 24 demonstrate that both methods can 
be successfully used to obtain highly enriched G1 populations of cells. However, 
since the elutriated cells contain actively growing G1 cells, whereas G1 cells in a 
serum deprived culture are in a quasi resting (G0) phase, it is not clear whether the 
results with these two different methods will be equivalent.  
This question was tested and the results shown in Figure 24. Immediately after 2 Gy 
IR, the ATM-pS1981 foci number rapidly increases and reaches a maximum within 
30-60 min. After this maximum, foci decay and their numbers reach background 
levels 6 h post IR. Similar results are obtained with elutriated-G1 populations and 
serum-deprived-G1 cells, which suggest that the state of growth has no influence on 
this cellular response. Moreover, a sophisticated staining was used to select G1 cells 
for analysis by excluding cyclin B1 positive cells (G2) and EdU positive cells (S) from 
the exponentially growing populations (explain later). It provides similar results as in 
synchronized G1 cells. Based on these results, we speculated that the evidence 
suggests ATM-pS1981 foci in G1-phase controlling the G2 arrest was very weak, 
since the foci decreased to the basal level before the cell moving into G2. 
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Figure 24. ATM-pS1981 foci kinetics in irradiated G1 cells. Exponentially growing A549 cells were 
synchronized at G1 phase either by serum deprivation or elutriation. The synchronies were examined 
by flow cytometry. Cells were exposed to 2 Gy IR and returned to the incubator. At the desired time, 
the cells were fixed, permeabilized and staining with anti ATM-pS1981 antibody. Foci numbers were 
scored and plotted against time. Inserted histograms indicate the cell cycle distributions before IR. The 
results are from 3 repeated experiments. Error bar stands for standard deviation.    
 
4.2.6 ATM-pS1981 kinetics in irradiated G2 cells 
Populations enriched in G2 cells were obtained by centrifugal elutriation from 
exponentially growing A549 cells. The G2 fraction was further confirmed by cyclin B1 
staining. The results in Figure 25 indicate that the percent of cyclin B1 positive cells 
increases slightly after irradiation and then decreases at later times as cells 
accumulate at metaphase due to the presence of nocodazole in the medium (176). 
Indeed the mitotic index increases after about 2 h and reached over 50% by 8 h. The 
time point when the mitotic index starts increasing and the fraction cyclin B1 positive 
cells starts decreasing can be taken as a measure of the G2-phase and is about 2-3 
h in this experiment. Follow up of ATM-pS1981 foci within these constraints provides 
information on the response of G2 cells. As expected, the number of ATM-pS1981 
foci peaked at about 1 h after IR and then started decaying quickly. At early times 
(30-60 min), the number of foci is evenly distributed among nuclei and the observed 
range is between 80 and 100. However, the number of foci per nucleus shows a 
considerably larger spread after longer incubation times. Notably, the distribution of 
foci number in the nuclei is not continuous and nuclei with less than 20 foci are rarely 
Time after IR [h]
0 2 4 6 8 10 12 14
Fo
ci
/n
uc
le
i
0
10
20
30
40
50 Elutriation G1
Serum deprivation 
DNA
0 256 512 768 102
400
350
300
250
200
150
100
50
0
DNA
0 256 512 768 102
300
250
200
150
100
50
0
G1=91% 
S=4.3% 
G2=4.6% 
G1=95% 
S=1.4% 
G2=3,1% 
Results                                                                            
 56
found at 4-8 h after IR, in Figure 25C. Co observation of a dramatic increase of 
mitotic index at these times suggests that cells have overcome G2 checkpoint and 
progressed into mitosis.  
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Figure 25. ATM-pS1981 foci kinetics in irradiated G2-phase cells. G2 populations were enriched 
by centrifugal elutriation from exponentially growing A549 cultures and plated on polylysine coated 
cover slips in the presence of nocodazole (0.04 μg/ml). After 30 min, cells were exposed to 2 Gy IR, 
and returned to 37 ºC for different periods of time. After desired time, cells were fixed, permeabilized 
and co-immunostained with anti ATM-pS1981and cyclin B1 antibodies. ATM-pS1981 foci numbers in 
cyclin B1 positive cells were scored. Cyclin B1 positive fractions were calculated. The MI was 
measured based on the mitotic morphology. At least 500 nuclei were scored.  The distributions of foci 
number as well as the mean foci numbers per nucleus are plotted as a function of time. MI and cyclin 
B1 positive fractions are also plotted against time. (A), Cell cycle distribution and cyclin B1 expression 
of the elutriated populations used in this experiment. ATM-pS1981 foci formation and cyclin B1 
expression 30 min after IR (blue DAPI, Red: ATM-pS1981 and Green: cyclin B1). (B), Left axis: the 
ATM-pS1981 foci kinetics. The absolute foci number in each nucleus is shown, as well as mean foci 
numbers per nucleus. Right axis: cyclin B1 positive fractions and MI variations. A hypothesised 
threshold (foci number = 20) is drawn in blue.  (C), The summary of foci frequency at each time point. 
(D), A detailed table about the foci frequency at each time point.  Unirradiated cells show less than 
5 foci per nucleus, which are not shown here.  The results are from 3 repeated experiments. Error 
bar stands for standard deviation. 
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4.2.7 Threshold to fully maintain G2 checkpoint  
On the basis of the above results we hypothesized that cyclin B1 positive cells could 
“ignore” 20 ATM-pS1981 foci that presumably signal to activate the checkpoint and 
progress to mitosis. This is compatible with requiring 20-foci either to activate or to 
maintain the G2 checkpoint. We previously showed that 1 Gy generates 24-27 ATM-
pS1981 foci in G1 cells and 50-55 foci in the G2 cells. Thus, 20 foci in cyclin B1 
positive cells are correspond to about 0.5 Gy. Hence 0.5 Gy might be a threshold 
radiation dose required to fully activate and then maintain the G2 checkpoint. To test 
this hypothesis, exponentially growing A549 cells were exposed to low radiation 
doses and the MI was measured by H3-pS10 staining as a function of time. The 
results are summarized in Figure 26. It is evident that 0.5 Gy causes a complete stop 
in cell progression into mitosis, which is in line with the full activation of the G2 
checkpoint. This result supports therefore our threshold hypothesis. Even a dose of 
0.1 and 0.2 Gy generates a clearly measurable inhibition of MI demonstrating 
activation of the G2 checkpoint after the induction of an estimated 5 and 10 foci per 
cell, respectively. In all cases examined the mitotic index recovered in a radiation 
dose dependent manner. For example after 2 Gy IR, which is the dosage used to 
study the ATM-pS1981 kinetics, the transition from G2 to M is blocked for about 4 h. 
After this time, MI recovers (Figure 26B), which is in line with the finding shown in 
Figure 25. 
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Figure 26. Mitotic index dose response in A549 cells. Exponentially growing A549 cells were 
exposed to different dose of IR. Samples were taken at each desired time point. Cells were fixed, 
permeabilized and stained with anti H3-pS10 antibody and PI. MI was measured by flow cytometry. MI 
is normalized by dividing against the MI from untreated samples. Normalized MI is plotted as a 
function of time. MI variation after 2 Gy IR is selected to show. (A), MI as a function of time after 
exposing to different IR dose Histogram indicates the cell cycle distributions before IR. (B) MI variation 
measured bivariate FACS after 2 Gy IR. The red arrow shows that some mitotic populations re-appear 
4 h after IR, which indicates that some cells are released from G2 checkpoint. 
 
4.2.8 ATM-pS1981 foci kinetics in S-phase cells 
Unlike G1 and G2 cells that have a uniform DNA content, cells in S-phase have a 
variable DNA content depending upon how far they have advanced in replicating 
their DNA. Centrifugal elutriation does not allow the selection of cell populations with 
a narrow DNA distribution within the S-phase of the cell cycle. Typically, S-phase 
populations obtained by centrifugal elutriation show a wide distribution in the S-phase 
component and contain variable amounts of G1 and G2 phase cells. Because the 
number of radiation induced foci is proportional to the DNA content, S-phase cells 
show a wide span in the number of foci scored ranging from the number measured in 
G1 cells to the number measured in G2 cells. Under such circumstance, studying the 
0 h 1 h 
2 h 4 h 
B 
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foci kinetics in S cells based on mean foci number is not meaningful. Therefore, in 
the analysis of the results obtained with S-phase cells, absolute foci distributions at 
each time point were used.  
As pointed out above, BrdU pulse labeling allows identifying S-phase cells. 
Unfortunately, immunofluorescence detection of BrdU requires harsh treatments to 
denature DNA and expose BrdU to the antibody. Such treatments damage the 
structural integrity of the cell and seriously compromise the detection of foci formed 
by proteins involved in the cellular response to DNA damage. To accommodate 
detection of this analog with the antibody staining required in our experiments to 
detect radiation-induced foci, we adopted a recent modification based on the 
replacement for BrdU with 5-ethynyl-2′-deoxyuridine (EdU, another analog of 
thymidine), which can be detected under milder conditions. Under such conditions, 
the foci formation of proteins involved in the DNA damage response  will not be 
dramatically altered (177).  
The EdU pulse labeling protocol allows the unequivocal identification of S-phase cells. 
Together with the utilization of cyclin B1 staining and taking advantage of the distinct 
mitotic morphology, allows the identification of cells in all four phases of the cell cycle 
in an exponentially growing population. For instance, G1 cells lack any staining and 
S-phase cells have clear EdU staining; G2 cells on the other hand are cyclin B1 
positive but EdU negative and do not show the typical mitotic morphology. 
With the help of this sophisticated staining protocol we analyzed ATM-pS1981 foci 
formation throughout the cell cycle in an exponentially growing culture of A549 cells 
exposed to 2 Gy and analyzed 1 h later. The results obtained are summarized in 
Figure 27.  
The similarity between foci distribution and the distribution of cells in the different 
phases of the cell cycle confirms previous results and provides a validation of the 
approach adopted here. Indeed, the foci number in G2 nuclei (cycin B1) is twice as 
high as the foci number in G1 nuclei, while the number of foci in S-phase cells lies 
between that of G1 and G2 cells.  
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Figure 27 ATM-pS1981 foci through the cell cycle distribution. Exponentially growing A549 cells 
were pulsed labeled with EdU for 30 min, and exposed to 2 Gy IR followed by a fresh media change. 
After 1 h incubation, cells were fixed and co-immunostained with anti ATM-pS1981, cyclin B1 
antibodies as well as EdU detection solution. ATM-pS1981 foci numbers in each nucleus were scored. 
Three experiments were carried and total of about 2000 nucleus were scored for foci. The nuclei were 
grouped according to their staining patterns as shown on top of the figure.  The numbers of nuclei 
with the same foci numbers were calculated. Nuclei counts are plotted as a function of foci number. 
(A), Typical view of ATM-pS1981, cyclin B1 and EdU co-staining. Mitotic cells are distinguished by 
their unique morphology, as indicted by an arrow. Color scheme: Red, ATM-pS1981; Green, cyclin 
B1; Cyan, EdU; Blue, DAPI. ATM-pS1981 foci are observed in every nucleus, except for mitotic nuclei. 
(B), ATM-pS1981 foci numbers per nucleus show a large spread depending on the cell cycle phase 
when the cells were irradiated. An increase of foci number is found with the increasing of DNA 
contents.  (C), The fractions of cells with unique staining pattern. (D), The cell cycle of the cell 
analyzed in this experiment. The MI was obtained from the previous experiments.   
 
The ATM-pS1981 foci kinetics in G1-phase cells are , which refers the cells only 
have DAPI signals, are found comparable to those measured using synchronized G1 
cells (see Figure 24). In G2-phase cells (cyclin B1 positive but without EdU signal), 
no nuclei with less than 20-foci are found (data not shown). Furthermore, the EdU 
signal migration indicated the transition of S-phase cells into subsequent phases of 
the cell cycle. EdU-cyclin B1 co-staining indicates the progression of S-phase cells 
into G2-phase, while EdU staining at mitosis indicates the progression of an S-phase 
cell at the time of irradiation into mitosis, Figure 28A.  
An estimate of cell cycle progression can be obtained by dividing the EdU-cyclin B1 
fraction by the total cyclin B1 fraction. In this way a measure of the fraction of G2 
cells originating from the S-phase can be obtained, Figure 28B. A similar calculation 
can also provide the fraction of cells that moved from the S-phase into mitosis. In this 
case, the fraction of EdU-stained mitotic cells is divided by the total fraction of mitotic 
cells, Figure 28C.  
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When analyzing the absolute number of foci in EdU positive cells, ie. in cells 
irradiated in S-phase independently of their location in the cycle at the time of 
analysis, we observed a peak within 30-60 min after IR, Figure 28D. This is similar to 
the observations made in G1 and G2 cells. However, these foci persist for longer 
times than foci in G1 and G2 even when cells undergo transition into G2. This 
indicates that during S-phase cells retain signaling activity, possibly waiting for entry 
into G2 to complete repair by HRR. There is a reduction in the number of foci after 2 
h, which coincides with the progression of S-phase cells into G2 and which is in line 
with repair occurring in this phase of the cell cycle. As S-phase cells move into M 
after about 6 h the number of residual foci is above 20 in line with the results 
obtained with G2 cells.  
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Figure 28. ATM-pS1981 foci kinetics in EdU positive cells. Exponentially growing A549 cells were 
pulsed labeled with EdU for 30 min, and exposed to 2 Gy IR followed by a fresh media change, as in 
Figure 27.  Cells were returned to 37 ºC for different periods of time. Cells were collected, fixed, 
permeabilized and co-immunostained with anti ATM-pS1981, cyclin B1 antibodies as well as EdU 
detection solution.  Color scheme: Red, ATM-pS1981; Green, cyclin B1; Cyan, EdU; Blue, DAPI. 
ATM-pS1981 foci numbers in EdU positive nuclei were enumerated. This experiment was repeated for 
three times and at least 500 nuclei were scored. (A),The transition of EdU positive cells in the cell 
cycle is monitored.  (B), The transition of EdU positive cells into G2-phase is quantified according to 
the equation shown in the figure, and plotted as a function of time. (C), The transition of EdU positive 
cells into M-phase is quantified according to the equation shown in the figure, and plotted as a function 
of time. (D), The distributions of foci numbers in each nucleus are plotted as a function of time. A 
hypothesized threshold (foci number = 20) is drawn in blue. The transition of EdU positive cells into G2 
and M are also incorporated.  (E), Summary of foci distribution at each time points. (F), A detailed 
table about the foci frequency at each time point.  Unirradiated cells show less than 3 foci per nucleus, 
which is not shown here.  The results are from 3 repeated experiments. Error bar stands for standard 
deviation. (G), Foci residues of 8 hours after IR. (Yellow number: foci number in the nuclei only stained 
with DAPI; White number: foci number in EdU + DAPI positive cells). 
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5  Discussion 
5.1 Are ATM and ATR working redundantly? 
Although ATM and ATR belong to the same family of protein kinases, it is quite 
unlikely that they function redundantly in mammalian cells. Loss of ATR in the mouse 
causes lethality at the earliest embryonic stages, whereas humans lacking functional 
ATM can live for decades (93,178). These observations suggest that ATR is crucial 
for basic biological processes. Since ATR detects and responds primarily to ssDNA, 
implying that the formation of this primed ssDNA structure in unperturbed cell cycles 
is at the heart of the matter (18).  One possibility is that ATR is activated at low levels 
in every cell cycle as a result of normal Okazaki-fragment dependent lagging-strand 
synthesis that leads to the transient formation of ssDNA. This activation might be 
required to enforce the order of S and M phase and to control origin timing (179). 
Mec1, the ATR homolog in yeast, has little to do with cell-cycle arrest or origin firing, 
but has fork-stabilization activity (96). 
The second possibility is that there are numerous stalled replication forks in cells 
never exposed to DNA damaging agents, as a result of endogenous DNA damage or 
at DNA sequences that are difficult to replicate. So ATR might have a major role in 
handling these forms of DNA damage and the associated replication stress (18). 
Overexpression of ATRkd does not change the viability of non-irradiated GM847-
ATRkd cells, while it significantly increases their radiosensitivity to killing (170). This 
suggests that second scenario might be true. In unperturbed mammalian cells, only a 
small portion of ATR might be required to handle the endogenous stress. If there was 
heavy loss of chromatin structure after exposure to IR, an increased activation of 
ATR may be required to mount a robust checkpoint response.  
AT patients, whose ATM function is defect, are suffered from hypersensitivity to 
ionizing radiation and have disrupted cell cycle control, but can live for decades (77). 
Many syndromes have been reported with symptoms overlapping those of AT. For 
example, mutations in NBS1 and MRE11 give rise to Nijmegen breakage syndrome 
(NBS) and ataxia-telangiectasia-like disorder (ATLD), respectively (180,181). All 
syndromes are in line with a compromised proteins involved in ATM pathway (77). 
High frequency of alternations in the same pathway without compromising the 
viability of the organism may suggest the ATM is not as critical as ATR. 
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Our finding also suggests that ATM and ATR seem to play different roles instead of 
acting redundantly to sense IR induced DNA damage and activate the G2 checkpoint. 
Inhibition of the ATR-Chk1 pathway caused an abrogation of IR induced G2 arrest 
without affecting ATM-pS1981 foci formation. On the other hand, inhibition of ATM 
disrupts ATM-pS1981 foci formation but only affects the G2 checkpoint when cells 
are irradiated in specific phases of the cell cycle. The delayed G2 accumulation of 
irradiated AT5-BIVA cells occurs 3 h later than in ATM competent cells. This  form of 
G2 arrest seems to be ATM-independent (172). Although strong G2 arrest is found in 
this case, some BrdU positive cells can escape the arrest and can migrate to the next 
cell cycle, Figure 12. These results suggest that the G2 arrest is only partially 
activated without ATM.  
Overall the above results provide clear evidence for a master role of ATR-Chk1 in the 
checkpoint response and ATM-Chk2 exerts in maintaining the signal. Our recent data 
also support the view that ATR and ATM contribute to G2 checkpoint in different 
ways. Briefly, 30 min after irradiation, addition of caffeine elevates the decreased MI 
back to the normal level within 15 min; while supplying KU-55933 has no effect (data 
not shown). Because ATRIP and ATM-pS1981 foci have been well developed 30-60 
min after IR, both pathways are believed fully activated, despite the fact that 
activation of the ATM pathway is faster than activation of ATR. These results suggest 
that ATR has to be continuously activated to enforce a G2 arrest; and that inhibition 
of ATM after ATM-pS1981 foci being formed does little in disrupting checkpoint 
response. 
5.2 How is the spatial distribution of ATM controlling the G2 
checkpoint? 
ATM-pS1981 and γ-H2AX foci decrease as cell remove DSBs from their DNA. Such 
resetting of chromatin could in principle be done either by replacing γ-H2AX in the 
nucleosome with H2AX, or by dephosphorylating γ-H2AX directly at the nucleosome 
(144). The dephosphorylation seems more dominant in this case (182,183). The 
dephosphorylation of γ-H2AX and ATM-pS1981 are much less understood than 
phosphorylation. It has been shown that the removal of the phosphor group is tightly 
bound to DNA repair (182,184). PP2A (protein phosphatase 2A) has been 
documented as a player in removing γ-H2AX (182). PP2A deficient cells have been 
found suffered from inefficient DNA damage repair, hypersensitive to DNA damage. 
They also display a long duration of γ-H2AX foci persistence. These observations 
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suggest that a proper disassembling of the foci is as important as their assembling 
(182,183). 
Phosphorylated protein aggregate to form foci might be a manner resisting improper 
dephosphorylation or disassociation, better than disperse protein. Compared with 
soluble form, protein foci have much smaller surface area, which limits the 
phosphates from accessing to them. So protein accumulated in concrete foci may be 
capable of maintaining signal transduction longer than disperse protein.  
In response to DNA damages, a noticeable retention of ATM in the chromatin is 
observed, which is unaffected upon ATM inhibition though chemical inhibitors (121). 
Such retention of ATM might generate a “source” for G2 arrest signal transduction. 
Furthermore, analysis of the spatial distribution of Chk2 reveals that after 
phosphorylation by ATM and subsequent activation at the sites of DSBs, 
phosphorylated Chk2 is rapidly distributed to the undamaged parts of the nucleus to 
reach its physiological targets, which is allowing for a coordinated pan-nuclear 
response to local DNA damage (185). These results are in line with our findings that 
although the formation of Chk2-pT68 foci and their colocalization with ATM-pS1981 
foci is a transient event (only observable 5-30 min after IR), the phosphorylation of 
Chk2 can be observed till 4 h after IR. On the other hand, our Western blots suggest 
that ATM-pS1981 can maintain its phosphor group much longer than Chk2-pT68. 
One possible explanation to this observation is that retention as a focus may prevent 
dephosphorylation as we suggested before. Hence, ATM-pS1981 spatial distribution 
as a focus at the site of a DSB might provide a platform for phosphorylation of Chk2, 
which then acts as a messenger to signal to downstream targets.  
From another point of view, due to their limited surface area, protein foci may be less 
efficient in activating their substrates as compared to disperse proteins. Western blot 
suggests that the phosphor group can be maintained in ATM-pS1981 foci longer, up 
to 8 h. A relatively high number of ATM-pS1981 foci might provide enough surface 
area to phosphorylate Chk2 to maintain G2 checkpoint the signal transduction. Such 
response may also explain the dose response of MI variation after exposure to IR. 
In vitro kinase assays suggest that 0.25 - 0.5 Gy is sufficient to activate ATM (141). 
In vivo, 0.5 Gy can efficiently induce ATM autophosphorylation at Ser1981, within 5 
min after irradiation (78). Our findings suggest that although notable G2 arrest can be 
observed as low as 0.1 Gy IR, 0.5 Gy (20 foci) is the minimal dose to 
maintain/activate the “full scale” G2 checkpoint in irradiated G2-phase cells. Using γ-
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H2AX as DSB index, cells with 20 γ-H2AX foci residue are found move freely into 
mitosis after irradiation (186). Hence, the spatial distribution of the 20 foci in a 
nucleus might ensure the minimal signal required to mount a complete G2 arrest; A 
larger number of foci (more than 20), corresponding to massive DNA damages, might 
help cells arrest in G2 for a longer period of time in order to signal serials events, 
such as HRR required to process the IR induced damages. Once the foci number 
drops to about 20, the phosphorylation level occurred on the total foci surface area is 
insufficient to maintain the G2 checkpoint signal cascade, thus releasing the cell from 
the block and allowing it to enter mitosis.  
5.3 Are the ATM-pS1981 foci DSB markers? 
γ-H2AX foci are widely used to evaluate IR induced DSBs, especially at low radiation 
doses (135,143). However, γ-H2AX foci formation is not IR specific (140). Other non-
DSB-inducing agents such as MNNG (N-methyl-N’-nitro-N-nitrosoguanidine), 
adozelesin (187), UVC, UVB, HU (hydroxyurea), APC (aphidicolin) (187,188), 
hyperosmotic stress (189) and heat stress (190) have been reported can induce γ-
H2AX foci. Spontaneous foci are also found in S-phase cells, probably due to the 
stalled replication forks during the replication (191). Although DSBs are not major 
products after these non-DSB-inducing treatments, there is no clear evidence that 
DSBs are absent at these γ-H2AX foci sites (187). As a result of this ambiguity, 
scoring γ-H2AX foci is still considered acceptable for analyzing induction and 
processing of DSBs. Since ATM-pS1981 foci colocalize with γ-H2AX, ATM-pS1981 
can be an alternative in this kind of assay. 
Even if γ-H2AX foci formation shows unequivocally the induction of DSBs, the 
reduction of γ-H2AX foci does not reflect the actual removal of the physical DSBs. 
When plateau-phase A549 cells are exposed to 1 Gy of X-rays, the full development 
of γ-H2AX foci requires 30 min and there is no reduction before 1 h. However PFGE 
shows an immediate reduction of the DSBs (induced by 20 Gy),  proceeding with half 
times of 20 min and with at least 80% of the DSBs being rejoined after 1 h (144). 
Similar results to γ-H2AX were obtained by studying ATM-pS1981 kinetics in our 
experiments. 
One possible explanation for the above discrepancy is that ATM-pS1981 or γ-H2AX 
foci, might not be appropriate markers for DSBs, but rather indicators of cellular 
metabolic activities initiated to facilitate and optimize DSB repair (144,192). In yeast, 
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the loss of γ-H2A foci (equivalent to γ-H2AX in higher eukaryotes) does not signify 
the removal of the discontinuity in the DNA (184). Therefore, it can be hypothesized 
that γ-H2AX or ATM-pS1981 foci continue marking the sites of some DSBs after 
processing and joining by NHEJ to facilitate additional processing, such as HRR 
(193,194).  
If this hypothesis is true, it will be particularly significant for ATM-pS1981 foci. ATM 
might be a key regulator of checkpoint, but instead of key player for DSB repair, 
since AT cells have been disrupted checkpoint activation but without gross defect in 
DSB repair (195). The formation of ATM-pS1981 foci (activated ATM) indicates that 
all DSBs induced by IR actually signal for checkpoint. And the persistence of ATM-
pS1981 foci indicates that the processing of DSBs is not completed even after they 
are rejoined by NHEJ; persistent foci may facilitate checkpoint maintaining or other 
events. 
5.4 What is the role of persist ATM-pS1981 foci in G2 checkpoint? 
ATM-pS1981 foci kinetics in G1 cells seems to be a relatively simple event. Foci 
distribution in each G1 nucleus is quite even, and 6 h after irradiation only 
background level of foci is observed. At this time, the cells are still in G1 or in S-
phase. 
The relationship between ATM activation and G2 arrest in cells irradiated during S-
phase seems to be a quite complex event. Since the S-phase cells have DNA 
content between that of G1 and G2 cells, the most straightforward model is to 
hypothesize that the ATM-pS1981 kinetics will be categorized as G1-like and G2-like. 
A 20-focus threshold is found in G2-like subpopulations in S-phase cells. There are 
no subpopulations in S-phase cells that share the fast ATM-pS1981 kinetics of G1 
cells. Another subpopulation of cells in the irradiated S-phase can maintain their foci 
and arrest in G2 for at least 6-8 h. Since these cells maintain 40-50 foci, it is quite 
likely they were irradiated in early S-phase. Furthermore 6-8 h maintenance of foci 
correlates well with the time frame required for maximal formation of Rad51 foci (our 
unpublished data), and for maximal interaction between ATR and ATRIP. Thus, a 
possible linkage between ATM/ATR activation and homologous recombination repair 
(HRR) is suggested.  
5.5 A possible model is raised. 
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Our results indicate that ATR is always involved in the maintenance of the G2 
checkpoint but can not come to the fore when cells are irradiated close to mitosis and 
ATM is not active. This result is in line with a linear transition of the G2 checkpoint 
responsibility from ATM to ATR: The lesion is first detected by DNA-PKcs and 
processed in such a way that it can be handed over to ATM. ATM in turn process 
further and hands it over to ATR after it has made it appropriate for HRR. All of these 
results allow us generating a hypothesized sequential model DNA-PKcs-ATM-ATR-
HRR in the processing of DSBs and as a consequence in the modulation of the cell 
cycle progression through the activation of checkpoints.  
Based on this model, in response to 2 Gy IR, DSBs (about 100-110) are registered 
by DNA-PKcs and ATM. ATM-pS1981 initiates the G2 checkpoint within less than 5 
min, and maintain the signal transduction at least 4 h. About 30 ATRIP foci are 
observed 3 h later indicates that ATR machinery has been recruited. By referring the 
initial ATM-pS1981 foci number, one can speculate that 25-30 % of the DSBs are 
handed over from ATM to ATR. At this time, about 10-15 Rad51 foci (Dr. Christian 
Staudt, unpublished data) are also observed that hints a potential direction to HRR.  
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6 Conclusions 
ATM-Chk2 and ATR-Chk1 pathways both contribute in maintaining proper G2 arrest 
after IR. ATR signaling plays a dominant role in the development of a full scale G2 
arrest, while ATM signaling helps in the maintenance of a full scale G2 arrest.  
In response to IR, ATRIP and phosphorylated ATM at serine 1981 can form foci. 
Although ATR plays a dominant role in G2 checkpoint signaling, its activation for G2 
arrest may not coincide with foci formation since visible foci form relatively late (1 h 
after IR). The contribution of ATM-pS1981 foci to G2 arrest is strongly dependent on 
the cell cycle phase in which the cell was irradiated. There exists an apparent 
requirement for about 20 foci for the maintenance of the G2 arrest for cells irradiated 
in G2-phase. There is no apparent correlation between ATM-pS1981 foci and G2 
arrest for cells irradiated in the G1-phase, as in this case foci disappear relatively 
quickly. Cells irradiated throughout S-phase, show a response similar to that 
observed with G2 cells and not, as one would expect, a mixed response reflecting 
subpopulations responding like G1 and subpopulations responding like G2 cells.  
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7 Abbreviations 
9-1-1 complex  Rad9, Rad1 and Hus1complex 
APC    aphidicolin 
AT    Ataxia-telangiectasia  
ATM    Ataxia-telangiectasia mutated 
ATM-pS1981  phosphoryaltion of ATM at Serine 1981 
ATR    ATM and Rad3-related  
ATRIP   ATR interaction protein 
ATRkd   ATR kinase dead 
ATRwt   ATR wild type 
BCA    bicinchoninic acid 
BrdU    5-bromo-2´-deoxyuridine  
BSA    Bovin serum albumin 
Chk2-pT68   Phosphorylation of Chk2 at Threonine 68 
Cyc B1   Cyclin B1 
DAPI    4'-6-Diamidino-2-phenylindole  
ddH2O   Double distilled water 
DMEM   Dulbecco's Modified Eagle Medium 
DMSO   Dimethyl sulfoxide 
DNA-PKcs   DNA-dependent protein kinase catalytic subunit 
DSB    DNA double strand break 
ECL    Enhanced chemiluminescence 
EDTA    Ethylenediaminetetraacetic acid 
EdU    5-ethynyl-2′-deoxyuridine  
FACS    Fluorescence Activated Cell Sorting 
FAT    FRAP,ATM,TRRAP  
FATC    FAT C-terminal  
FBS    Fetal Bovin Serum 
FITC    Fluorescein isothiocyanate 
FS    Forward scatter 
Gy    gray 
H3-pS10   phosphoryaltion of Histone H3 at Serine 10 
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HEAT  Huntingin, elongation factor 3 (EF3), protein phosphotase 
2A (PP2A), TOR1  
HRP    Horseradish peroxidase 
HRR    Homologous recombination repair 
HSFM    Hybridoma serum free media 
HST    Histrograme  
HU    Hydroxyurea 
IR    Ionizing radiation 
KU-55933 KUDOS55933 (2-morpholin-4-yl-6-thianthren -1-yl-pyran-
4-one) 
LIF    Leica image format 
McAb    Monoclonal antibody 
MI    Mitotic index 
MNNG   N-methyl-N’-nitro-N-nitrosoguanidine 
MPF     Mitosis promotion factor 
MQ    Milli-Q 
MRN     Mre11, Rad50 and Nbs1 complex 
MW    Molecular weight 
NBS    Nijmegen breakage syndrome  
NHEJ    Nonhomologous end-joining 
NLS    Nuclear Localizatin Signal domain  
NU-7026   2-(Morpholin-4-yl)-benzo[h]chomen-4-one 
PBG    PBS, BSA, Gelatine 
PBS    Phosphate Buffered Saline 
PBST    PBS with Tween 20 
PcAb    Polyclonal antibody 
PCC    Prematurely condensed chromosomes 
PCNA    Proliferating cell nuclear antigen  
PFA    Paraformaldehyde 
PFGE    Pulsed field gel electrophoresis  
PI    Propidium iodine  
PI-3Ks   Phosphoinositide-3 lipid family of kinases  
PMT     Photomultipliers 
PP2A    Protein phosphatase 2A 
PVDF    Polyvinylidene Fluoride Transfer Membranes 
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Rnase   Ribonuclease 
RPM    Rounds per minute 
RT    Room temperature 
SDS-PAGE  Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
Ser    Serine 
SS    Side scatter 
ssDNA   Single-stranded DNA 
TAg    Tumor antigen 
tet    Tetracycline 
Thr    Threonine 
TIFF    Tagged Image File Format 
TOPBP1   Topoisomerase-binding protein-1 
Tyr     Tyrosine 
UCN-01   7-hydroxystaurosporine  
UV    Ultraviolet 
γ-H2AX   Phosphoryaltion of Histone H2AX at Serine 139 
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9 Appendix 
9.1 Appendix 1: Buffers and Solutions 
1. 1X Phosphate Buffered Saline (PBS)  
Dissolve the following in 800ml Double distilled water (ddH2O). 
• 8 g of NaCl 
• 0.2 g of KCl 
• 1.44 g of Na2HPO4 
• 0.24 g of KH2PO4  
Adjust pH to 7.4. 
Adjust volume to 1 L with additional ddH2O. 
Sterilize by autoclaving and store at 4°C. 
2. Trypsin-EDTA (Trypsin0.05%, EDTA 0.02%) 
 0.5 g of Trypsin 
 0.2 g of EDTA 
 Adjust the volume to 1 L with 1X PBS. 
Sterilize by passing through 0.22 μm filter and store at -20°C. 
3. Sodium azide (NaN3 0.02%) 
10 g of NaN3 
 Adjust the volume to 100 ml with ddH2O. 
Store at RT. 
4. BrdU stock solution (10mM) 
0.307 g of BrdU 
Adjust the volume to 100 ml with 1X PBS. 
Sterilize by passing through 0.22 μm filter and store at -20°C in dark. 
5. 100X Propidium iodine. (4 mg/ml) 
400 mg of PI 
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Adjust the volume to 100 ml with ddH2O.  
Store at -20°C in dark. 
6. 100X RNase. (6.2 mg/ml) 
620 mg of BrdU 
Adjust the volume to 100 ml with MQ  
Store at -20°C in dark.  
7. 100X Nocodazole (40 μg/ml) 
400 μg of Nocodazole 
Adjust the volume to 10ml with DMSO. 
Store at -20°C in dark.  
8. 1M HCl 
Add 10 ml 12M HCl to 50 ml ddH2O. 
Adjust the volume to 120ml with ddH2O. 
Store at RT.  
9. 4x Tris/SDS pH 6.8 stacking gel buffer 
Dissolve 6.05 g Tris-base in 40ml ddH2O. 
Adjust pH to 6.8 with 1 N HCl. 
Add H20 to 100 ml. 
Add 0.4 g SDS. 
Store at 4°C. 
 
10. 4x Tris/SDS pH 8.8 resolving gel buffer 
Dissolve 91 g Tris-base in 300 ml ddH2O. 
Adjust to pH 8.8 with 1 N HCl. 
Add H2O to 500 ml. 
Add 2 g SDS. 
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Store at room temperature  
11.  5x SDS electrophoresis buffer 
15.1 g Tris-base 
72.0 g glycine 
5.0 g SDS 
Add ddH2O to 1000 ml. 
Store at room temperature.  
12. 6x SDS sample buffer 
7 ml 4x Tris/SDS pH 6.8 stacking gel buffer 
3.0 ml glycerol 
1 g SDS 
0.93 g DTT (dithio-threitol) 
1.2 mg bromophenol blue 
Add ddH2O to 10 ml. 
Store in 1 ml aliquots at -20°C.  
13. 1X Transfer Buffer (Western blot transfer buffer) 
Dissolve the following in 1600ml ddH2O. 
• 28.8 g of glycine 
• 6.04 g Tris base 
Add 200 ml methanol. 
Adjust the volume to 2000 ml with ddH2O. 
Store at 4°C. 
14. Tween-20 20%  
200 ml Tween-20 
Adjust the volume to 1000ml with ddH2O.  
Store the solution at RT in dark.  
15. PBST (PBS+0.05% ,Tween-20, washing buffer)   
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2.5 ml 20% Tween-20  
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark.  
16. PBST-milk (PBST+5% ,Tween-20, washing buffer)   
5g of milk (blot grade) 
Adjust the volume to 1000 ml with ddH2O. 
Store the solution at 4°C in dark.  
17. 2% PFA (paraformaldehyde, fixation solution) 
10 g PFA  
450 ml ddH2O 
Heat to 50°C  
Add a drop 1 N NaOH to bring PFA into solution. 
Adjust the volume to 500 ml with ddH2O. 
Store the solution at -20°C in dark.  
18. PBG (PBS-BSA 0.5%-Gelatin 0.2%, blocking buffer) 
450 ml ddH2O 
1g Gelatine (boil at 50°C to dissolve and cool down) 
2.5 g BSA 
Adjust the volume to 500 ml with ddH2O. 
Store the solution at -20°C in dark.  
19. P-solution (Permeabilization buffer) 
2.43 g Tris-base 
3.72 g EDTA 
1 ml Triton X-100 
Adjust pH7.4 with 1 M HCl. 
Add ddH2O to 200 ml. 
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Store the solution at 4°C in dark.  
20. DAPI stock solution 
10 mg DAPI 
10 ml ddH2O 
Store the solution at -20°C in dark.  
21. FACS Permeabilization solution (PBS + 0.25% Triton X-100) 
2.5 ml Triton X-100 
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark.  
22. FACS blocking buffer (PBS + 0.05% Tween-20 + 1% BSA) 
10 g BSA 
2.5 ml 20% Tween-20  
Adjust the volume to 1000 ml with PBS. 
Store the solution at RT in dark.  
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Cell line Doubling time 
Mean size 
(μm) Media
Initial 
Number cell type Genotype
A549 20 h 14,6 McCoy's 0,5 M adenocarcinoma wt
AT5BIVA 30 h 16,67 MEM 1 M  fibroblast ATM deficient
GM847 ATRkd 30 h 18,65 MEM 1 M fibroblast ATR kinase dead
MO59 J 30 h 13,8 DMEM 1 M glioblastoma DNA-PKcs deficient
MO59 K 20 h 15,5 DMEM 0,4 M glioblastoma wt
HCT116 DNA-PKcs-/- 31 h 14,7 McCoy's 1 M carcinoma DNA-PKcs deficient
HCT116 wt 24 h 13,2 McCoy's 0,5 M carcinoma wt
F0298 35 h 16,2 MEM 2M fibroblast ATR defect
DK0064* 22 h 11,3 DMEM 0,3M lymphoblastoid ATR defect
9.2 Appendix 2: Cell line information 
 
Cells were maintained at 37°C with 5% CO2.  10% FBS were supplemented to the media.  
 
 
 
 
 
 
 
 
 
 
 
 
 
** DK0064 grows in a suspension form. 
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9.3 Appendix 3: Settings for cell cycle analysis 
 
Cell cycle analysis programme settings 
 
Flow cytometry:    COULTER EPICS XL  
Sheath Speed:    middle 
 Total cells sampled:   20000 
 Maximal running duration:  900 seconds 
 Working mode:    carousel 
 
             cell line   
Paramater A549 AT5-BIVA GM847 wt
GM847 
ATRkd F0298 DK0064 MO59 J MO59 K
HCT116 
DNAPkcs-/- HCT116 wt
Exicitation (nm) 488 488 488 488 488 488 488 488 488 488
Filter spectrum (nm) 655-735 655-735 655-735 655-735 655-735 655-735 655-735 655-735 655-735 655-735
FS-PMT (volt) 55 55 55 55 55 55 55 55 55 55
FS-Gain 2 2 2 2 2 2 2 2 2 2
SS-PMT (volt) 400 400 400 400 400 400 400 400 400 400
SS-Gain 1 1 1 1 1 1 1 1 1 1
AUX-PMT (volt) 300 300 300 300 300 300 300 300 300 300
AUX-Gain 2 2 2 2 2 2 2 2 2 2
PI-PMT (volt) 530 520 520 520 530 530 540 545 560 550
PI-Gain 2 2 2 2 2 2 2 2 2 2
Discriminator PI>3 PI>3 PI>3 PI>3 PI>3 PI>3 PI>3 PI>3 PI>3 PI>3
Gate single cell single cell single cell single cell single cell single cell single cell single cell single cell single cell
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9.4 Appendix 4: Settings for bivariate flow cytometry 
Flow cytometry:    COULTER EPICS XL  
Sheath Speed:    middle 
 Total cells sampled:   20000 
 Maximal running duration:  900 seconds 
 Working mode:    Manual 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Programe   
Paramater
DNA-PI          
BrdU-FITC
DNA-PI          
Cylin B1-FITC
DNA-PI          
H3-pS10-FITC
FS-PMT (volt) 55 55 55
FS-Gain 2 2 2
SS-PMT (volt) 400 400 400
SS-Gain 1 1 1
AUX-PMT (volt) 300 300 300
AUX-Gain 2 2 2
Excitation of PI 488nm 488nm 488nm
PI- Filter spectrum 655-735nm 655-735nm 655-735nm
PI-PMT (volt) 530 520 520
PI-Gain 2 2 2
PI signal Linear Linear Linear
PI-GATE single cell single cell single cell
Discriminator PI>3 PI>3 PI>3
Excitation of FITC 488nm 488nm 488nm
FITC Filter 490-550nm 490-550nm 490-550nm
FITC-PMT (volt) 530 520 520
FITC-Gain 2 2 2
FITC signal Logarithm Linear Linear
FITC-GATE FITC positive FITC positive FITC positive
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9.5 Appendix 5: Settings for western blot and 
immunofluorescence 
 
1. Setting for SDS-PAGE 
 
2. Setting for electrotransfer 
 
3. Antibody dilution for western blot and ECL exposure duration 
 
 
 
 
 
 
 
 
 
** ATRIP hybridoma culture supernatant 
 
 
4. Antibody dilution for immunofluorescence 
 
 
 
 
** ATRIP hybridoma culture supernatant 
Protein Gel conc 
Constant 
Voltage (V)
Running time 
(min) Temp MW (KD)
ATM 8% 150 90 RT 370
ATM-pS1981 8% 150 90 RT 370
ATR 8% 150 90 RT 301
ATRIP 10% 150 90 RT 85
Chk2 12% 150 90 RT 68
Chk2-pT68 12% 150 90 RT 62
GAPDH 12% 150 90 RT 38
LAMIN 12% 150 90 RT 70
Protein Name Membrane
Transfer 
Voltage (V)
Transfer time 
(min) Temp (°C )
ATM PVDF 110 75 0
ATM-pS1981 PVDF 110 75 0
ATR PVDF 110 75 0
ATRIP PVDF 110 75 0
Chk2 PVDF 100 60 0
Chk2-pT68 PVDF 100 60 0
GAPDH PVDF 100 60 0
LAMIN PVDF 100 60 0
Protein Name
Primary 
Antibody
Secondary 
Antibody
Image exposure duration 
(seconds)
GAPDH 1:20000 1:20000 50
ATM 1:800 1:1500 120
ATM-pS1981 1:800 1:1500 165
ATR 1:800 1:1500 150
ATRIP 1:10 ** 1:1000 120
Chk2 1:1000 1:2000 120
Chk2-pT68 1:800 1:2000 160
LAMIN 1:500 1:1000 120
Protein Name Primary Antibody Secondary Antibody
ATM-pS1981 McAb 1:300 1:400
ATM-pS1981 PcAb 1:300 1:400
ATRIP 1:5** 1:400
Chk2-pT68 1:300 1:400
Cyclin B1 PcAb 1:300 1:400
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5. Antibody dilution for bivariate flow cytometry 
 
 
 
 
Protein Name Primary Antibody Secondary Antibody
BrdU McAb 1:200 1:300
H3-pS10 PcAb 1:150 1:200
Cyclin B1 PcAb 1:150 1:200
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9.6 Appendix 6: Settings for microscope and Imaris 
 
Settings for Leica SP5 confocal microscope 
 
Instrument Parameter Setting:  Confocal LDM      Argon laser intensity:  50% 
Objective:    HCX PL APO lambda blue 63.0x1.40 OIL UV  Speed:    400Hz 
Image size:    246.03 μm x 246.03 μm     
 Pixel size:    481.46 nm x 481.47nm        
Sequential Scan:   between stacks 
Lineal Average: 1  Accum: 1 
Frame Average: 1  Accum: 1 
Scan direction:   bidirection       Step size:    0.5 μm 
Resolution:    512x512 
 
 
 
             Programe    
Paramater DAPI
ATM-pS1981  
Alexa 488
ATM-pS1981  
Alexa 568
Chk2-pT68 
Alexa 488
Chk2-pT68   
Alexa 568
ATRIP       
Alexa 488
Cyclin B1 
Alexa 488
Cyclin B1 
Alexa 568
EdU         
Alexa 647
Excitation 405 nm 488 nm 561 nm 488 nm 561 nm 488 nm 488 nm 561 nm 633 nm
Laser intensity 16% 23% 32% 23% 32% 23% 23% 32% 29%
 Filter range 420-530nm 495-550 nm 620-700 nm 495-550 nm 620-700 nm 495-550 nm 495-550 nm 620-700 nm 646-733 nm
PMT 850 V 540 V 720 V 580 V 720 V 580 V 650 V 780 V 480 V
Smart gain offset -2% -5% -5% -5% -5% -5% -2% -2% -2%
minimal foci size 
(Imaris) 0,5μm 0,5μm 0,5μm 0,5μm 0,5μm
Imaris threshold 17 17 21 23 19
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